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ABSTRACT 
 
In the genomic era, advanced sequencing techniques have enabled an exponential 
growth of the protein sequence databases. Although the abundance of genomic sequences 
is valuable, the correctness of the gene annotations poses a problem--approximately one-
half of the deposited sequences are incorrectly annotated.  We are using the enolase 
superfamily as a model system to try to solve that problem. To date, >4000 members 
have been identified in the enolase superfamily, of which ~50% have unknown functions.  
The muconate lactonizing enzyme (MLE) subgroup contains a family of enzymes that 
catalyze the epimerization of dipeptide substrates. Identification of function of unknown 
members of the MLE subgroup, based on sequence information and homology modeling, 
has been successful.  A novel D-Ala-D/L-Ala and a unique L-Ala-D/L-Glu epimerase 
(AEE) were identified and kinetically characterized from Cytophaga hutchinsonii (kcat/KM 
of 5.5 x 104 M-1s-1) and Bacteroides thetaiotaomicron (kcat/KM of 5.8 x 10
4 M-1s-1), 
respectively.  Computational predictions, provided by Prof. Matthew Jacobson’s 
laboratory at UCSF, were proven correct for both enzymes.  In collaboration with Prof. 
Steven Almo’s laboratory at Albert Einstein College of Medicine, an X-ray crystal 
structure was solved at 1.6 Å resolution for the B. thetaiotaomicron AEE, establishing the 
correctness of the predicted homology model. 
Many enzymes in the mandelate racemase (MR) subgroup catalyze dehydration of 
various acid-sugar substrates.  Attempts were made to elucidate the biochemical function 
of previously uncharacterized MR subgroup members from Agrobacterium tumefaciens, 
Mesorhizobium loti, Polaromonas sp., Silicibacter sp. and Sinorhizobium meliloti.  
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The glucarate degradation operon in Escherichia coli encodes two enolase 
superfamily members: D-glucarate dehydratase (GlucD) and its catalytically impaired 
close homologue, GlucD related protein (GlucDRP).  However, the function of GlucDRP 
is unclear. New biochemical evidence suggests that GlucD and GlucDRP are interaction 
partners in vivo. The role of several residues in catalysis and substrate recognition from 
the capping domain loops were investigated via a mutagenesis study of GlucD. 
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CHAPTER 1. ITRODUCTIO 
1.1. Evolution of enzyme activity 
1.1.1. Mechanisms of enzyme evolution 
There are two major theories of how enzyme evolution could occur. Enzymes that 
are related through sequence and structure are predicted by the first theory – divergent 
evolution. Divergently related enzymes arise from a common progenitor and retain some 
features of the ancestral enzyme (e.g. sequence, common structural fold, active site 
structure, or the strategy for catalyzing a type of reaction). Divergently related enzymes 
are homologous but can share as little as 10% sequence identity [1]. The homology of 
highly diverged enzymes, however, is not always obvious by just gazing at the sequence 
and may become apparent only by comparing the three-dimensional structures of the 
selected enzymes [2, 3]. 
The second theory follows the path of convergent evolution where the enzymes 
can catalyze a common reaction without being related through sequence space. This also 
means that the same reaction can be catalyzed via alternative mechanisms and by 
alternative active site structures, utilizing potentially different reaction intermediates but 
resulting in an identical product – these are called analogous enzymes 
 
1.1.2. Divergent evolution of enzyme function 
The premise for divergent evolution of enzymes involves a gene duplication event 
where the progenitor will retain the original function and the copy will evolve to give 
selective advantage to the organism [1-3]. There are four basic strategies that Nature can 
utilize to divergently evolve enzyme function. The first is by keeping the substrate 
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specificity dominant; Horowitz  proposed that enzymes can “evolve backwards.” In his 
proposal, Horowitz describes that, when the substrate for an enzyme is depleted in the 
growth environment, a set of enzymes will have to evolve to supply the first enzyme with 
its substrate [4]. This, however, does not mean that the newly evolved enzymes in the 
novel pathway are structurally or mechanistically related to the first enzyme. The second 
possibility would be to retain the general mechanism of the enzyme through which the 
course of evolution has fine-tuned the ability to catalyze energetically otherwise difficult 
reactions. By selective advantage, parts of the enzyme that are involved in substrate 
recognition are free to evolve to accommodate new substrates. The third hypothesis 
excludes the dominance of both substrate specificity and a conserved enzyme 
mechanism, thus relying on the active site architecture as the starting point for 
divergence. While the active site architecture, such as the ligands for co-substrates or the 
catalytic residues, had evolved to facilitate certain types of reactions, other parts of the 
protein can undergo change to grant selective advantage for the organism [2, 3]. The 
fourth mechanism, as proposed by O’Brien and Herschlag, takes advantage of the fact 
that some enzymes are promiscuous and can utilize more than a single substrate, albeit at 
low levels of activity. The mechanism is dependent on a gene duplication event and 
requires very minimal change to the progenitor enzyme improve over the ancestral 
enzyme function [1]. After a certain threshold level of activity has been achieved, the 
enzyme is free to fully optimize for the catalysis of a new reaction. The measure of 
threshold level is the enzyme’s ability to grant selective advantage for the organism. 
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1.1.3. Enzyme superfamilies 
Several of the strategies discussed in the previous section are the means by which 
enzyme superfamilies are being populated through the course of evolution. Superfamilies 
are groups of homologous enzymes that share some of the following characteristics: 
overall fold, conserved active site residues, partial reaction mechanism or the strategy for 
generating a reaction intermediate. Strikingly, even though enzymes in a superfamily can 
generally be structurally aligned with a low root mean square deviation, members in a 
superfamily can share as little as 10% in sequence identity. However, typically that 
number is higher, about 50% or less. As of 2007, based on the analysis of the 34,495 
Protein Data Bank (PDB) entries, the Structural Classification of Proteins (SCOP) 
database has identified a total of 1777 superfamilies [5]. Many of the superfamilies found 
in the SCOP database are populated by a single structure; however, a few are populated 
by hundreds or thousands of proteins. Two such examples are the mechanistically diverse 
enolase and amidohydrolase superfamilies [3]. Members of both superfamilies each 
catalyze mechanistically diverse reactions with a broad range of substrates while utilizing 
the central TIM-barrel architecture. Reactions in the enolase superfamily branch from a 
common mechanistic feature which is the abstraction of the α-proton from an anionic 
substrate followed by β-elimination of water or ammonia, 1,1-proton transfer or 
cycloisomerization. The enolate intermediate is stabilized by a divalent metal ion, which 
is usually Mg2+. Most enzymes in the amidohydrolase superfamily catalyze hydrolysis 
reactions where the scissile bond is either P-O for phosphotriesterases or C-N for urease 
and deaminase reactions. Although the members in the enolase superfamily are usually 
dependent on a single Mg2+ ion for catalysis, members in the amidohydrolase 
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superfamily utilize either two Ni2+, two Zn2+ or a single Zn2+ ion [3]. The metal ions in 
the amidohydrolase superfamily can also serve different roles in catalysis whereas in the 
enolase superfamily, the Mg2+ ion always serves to stabilize the enolate intermediate. 
 
1.2.  TIM-barrel fold as a scaffold for divergent evolution 
1.2.1. Origins of the TIM-barrel fold 
Approximately 10% of all known protein sequences have been estimated to 
contain the TIM-barrel fold, making it the most abundant enzyme fold in the nature [6, 
7]. The TIM-barrel is made up of eight, parallel β-strands which are connected by eight 
α-helices. The β-strands make up the β-barrel, and the α-helices form the outer layer of 
the barrel. The active sites for all known TIM-barrel containing enzymes are located at 
the C-terminal end of the barrels. The residues that make up the active site are found in 
the loops connecting the α-helices and β-strands. In 2000, Sterner and coworkers 
provided evidence for one hypothesis of how the TIM-barrel structure could have 
evolved. The hypothesis includes a gene duplication event and fusion of an ancestral 
(β/α)4-or half-barrel structure, which would go through additional optimization to 
provide a stable structural scaffold for enzyme catalysis [8]. As an alternative, it is 
possible that the full barrel evolved in steps from quarter barrel units, to half, and then to 
a complete (β/α)8 barrel. Partly due to its natural abundance and stability, it has been 
proposed that perhaps the TIM-barrel fold is a product of convergent evolution [6, 9].  
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1.2.2. Evolutionary potential of the TIM-barrel fold 
Due to the large number of TIM-barrel enzymes in the nature, one can clearly see 
the vast evolutionary potential of this fold to facilitate novel reactions and substrate 
specificities. In a few recently published research articles, it has been shown that the 
substrate specificity and even the reaction mechanism of the enzyme can be changed by a 
limited number of amino acid deletions or substitutions [10, 11]. The structural stability 
of the TIM-barrel fold provides a starting-point from which Nature can tinker to provide 
the selective advantage an organism needs. One of the examples involves an enolase 
superfamily member, L-Ala-D/L-Glu epimerase (AEE) from Escherichia coli that is 
involved in the peptidoglycan component recycling. The wild type AEE from E. coli 
catalyzes the 1,1-proton transfer reaction from the L-Ala-D/L-Glu substrate equilibrating 
the two diastereomers. However, a homologue of AEE, o-succinylbenzoate synthase 
(OSBS), catalyzes the β-elimination of water from SHCHC substrate. OSBS is one of the 
enzymes in the menaquinone biosynthetic pathway in E. coli. Many of the enolase 
superfamily members are functionally promiscuous. In addition to the natural substrate, 
these superfamily members can usually utilize structurally similar substrates with reduced 
catalytic efficiency. The wild type AEE catalyzes the dehydration of SHCHC with a 
kcat/KM ≤ 5.2 x 10
-3 M-1s-1, several orders of magnitude lower than the wild type OSBS-
catalyzed reaction of 1.8 x 106 M-1s-1. A single mutation in the AEE active site can raise 
the catalytic efficiency to 7.4 M-1s-1, and a triple mutant raises the kcat/KM even further to 
2.1 x 103 M-1s-1 [11]. Flexible loops in this otherwise stable barrel fold allow for highly 
evolvable enzymes.  
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1.3. Genomic enzymology 
Since the advent of high-throughput sequencing techniques, the protein sequence 
databases have grown exponentially. Whole genome sequences from various life forms 
and extreme environmental conditions provide new insights as to how evolution could 
have occurred and help us understand Biochemistry. A new term, genomic enzymology, 
was coined by Gerlt and Babbitt in 2001 which tries to tie together the multiple aspects of 
genomic information (sequence families, structures, and functions) to answer the very 
basic questions of enzymology [3]. Genomic enzymology in essence provides the 
strategy for understanding the structure-function relationships and of enzyme catalysis.  
 
1.3.1. Challenges for the genomic era 
Although the abundance of new sequence information is important, due to the 
lack of accurate annotation methods, the annotation information about a specific enzyme 
can be misleading or even wrong. Mechanistically diverse superfamilies are often subject 
to misannotation because the sequence identity between superfamily members can be as 
low as 10%. To date, about 50% of the sequences in the enolase superfamily are of 
unknown function [12]. These unknowns, however, have been assigned with specific 
enzyme functions in the NCBI non-redundant protein sequence database. The correct 
annotation of enzymes becomes increasingly more difficult with very divergent 
superfamily members. Therefore, a more thorough and sophisticated methodology is 
required to infer function from the primary structure of an enzyme. 
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1.3.2. Strategies to resolve the annotation problem 
In order to gain some fundamental understanding of a complex problem, scientists 
usually turn to model systems. To tackle the problem of functional assignment of 
enzymes based on sequence information alone, a similar strategy can be utilized. Using a 
genomic enzymology approach, the enolase superfamily has proven to be an excellent 
model system in trying to answer the question of how to infer function from protein 
sequence. This approach combines bioinformatics, computational biology, x-ray 
crystallography and experimental biochemistry techniques to develop the complex 
computational algorithms needed for correct annotation. The basic steps in the process 
include a thorough bioinformatic analysis (e.g. classification into families, operon 
context), homology modeling based on previously solved crystal structures, high-
throughput in silico docking of compound libraries, biochemical characterization and x-
ray crystallography of the enzyme in question [13, 14].  
 
1.4. The enolase superfamily 
Superfamilies are defined as groups of homologous enzymes that have maintained 
the same overall three-dimensional structure and catalytic residues but can utilize a 
diverse set of substrates with common functional groups (Figure 1.1). The enolase 
superfamily is one such large superfamily that to date is comprised of more than 4000 
members. It is a mechanistically diverse superfamily that can catalyze the following 
reactions: β-elimination of water and of ammonia, cycloisomerization of cis,cis-
muconate, epimerization of dipeptides,  racemization of N-succinylamino acids and of 
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mandelate. All reactions in the enolase superfamily are initiated by the abstraction of an 
α-proton to a carboxylic acid [2]. 
 
1.4.1. Overview: conserved structural and functional elements. 
The “canonical” members that were first identified in this superfamily were 
mandelate racemase (MR) and muconate lactonizing enzyme (MLE). Though at the time 
no superfamily per se existed, it was clear that the two proteins were close structural 
homologues of enolase [15]. Enolase superfamily members in broad terms have a (β/α)8-
barrel fold. The (β/α)8-barrel domain makes up the C-terminal portion of the bidomain 
enzyme, harboring the residues that are important for acid-base catalysis and metal 
binding. Elements that effectively play key roles in substrate recognition reside in the 
α+β capping domain that is formed by both the N- and C-terminal segments of the 
polypeptide. The capping domain is less conserved than the barrel portion of these 
enzymes. This in turn is responsible for the wide variety of structurally dissimilar but 
carboxylate containing compounds that the superfamily members can utilize as 
substrates. 
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Figure 1.1. Representatives from the six subgroups of the enolase superfamily: 
Enolase, mandelate racemase (MR), muconate lactonizing enzyme (MLE), glucarate 
dehydratase (GlucD), mannonate dehydratase (ManD) and methylaspartate 
ammonia-lyase (MAL). 
 
1.4.1.1. C-terminal (β/α)8-barrel domain. 
In an attempt to identify new enolase superfamily members with divergent 
substrate specificities, a few criteria must be met. The first criterion is the presence of the 
catalytic and metal binding residues. The barrel domain has evolved such that the 
residues required for catalysis reside at the C-terminal ends of the β-strands and point 
towards the center of the barrel [16]. Structurally, due to the absence of the final α-helix 
in the barrel portion of the protein, the fold in stricter terms is a (β/α)7β-barrel (Figure 1. 
2). The acid-base catalysts are located on the opposing sides of the barrel, either at the 
ends of the second and sixth or at the ends of the second, sixth and seventh β-strands. In 
addition to acid-base catalysts, the key to recognizing new enolase superfamily members 
Enolase   MR    MLE 
GlucD    ManD    MAL 
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is the presence of metal binding ligands that coordinate to the catalytically essential 
divalent metal ion, which is usually Mg2+. The metal binding ligands are at the C-
terminal ends of the third, fourth and fifth β−strands. The identities of the conserved 
metal binding ligands and catalytic residues allow enolase superfamily members to be 
further categorized into subgroups. Elements for substrate recognition that are provided 
from the barrel portion of the bidomain enzyme lie in some cases at the end of the eighth 
β−strand. The residues at the C-terminal end of the eighth β−strand provide additional 
hydrogen bonding interactions for the tight binding of the substrate. One such example is 
the DxD motif that is present in all dipeptide epimerase family members in the MLE 
subgroup [14]. The carboxylate anions from the DxD motif form a strong ionic bridge 
with the α-ammonium group of the substrate [17], therefore defining the specificity for a 
broad range of dipeptides. 
      
Figure 1.2. The most conserved feature amongst the >4000 enolase superfamily 
members is the (β/α)7β-barrel; depicted is the barrel portion of P. putida MR. 
 
90º 
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1.4.1.2. &-terminal capping domain 
Although the capping domain is often referred to as the N-terminal domain, in 
reality it is composed of both the C- and N-terminal sections of the polypeptide. The 
capping domain is also the part of the protein that has undergone the greatest number of 
modifications throughout the course of divergent evolution. The core of the capping 
domain is made up of a number of α+β repeats and of loop structures that close over the 
active site, excluding water and pushing the substrate in place for catalysis. It is the loop 
structures that are thought to provide the interactions necessary for specific substrate 
recognition [2]. In the case of the dipeptide epimerase family, which will be discussed in 
greater detail later, it is thought that the interactions from 20s loop define the substrate 
specificity for the C-terminal portion of the dipeptide substrate. For example, in the 
canonical L-Ala-D/L-Glu epimerase from Bacillus subtilis, an Arg24 residue forms an 
ionic bridge with the γ-carboxylate group of the glutamate moiety, defining the 
specificity for that substrate [17]. Another example of a specific set of interactions from 
the capping domain is the enolase from Saccharomyces cerevisiae where the binding to 
the 2-phosphate group of 2-phosphoglycerate (2-PGA) is mediated through a complex 
network of interactions from the 40s loop in conjunction with residues from the barrel 
portion of the enzyme [18]. 
 
1.4.1.3 Functional elements 
Although both barrel and capping domains of the polypeptide are important for 
catalysis, the barrel portion of the enzyme contains the residues that are involved in 
specific types of reactions. Based on the identities of the active site residues, members of 
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the superfamily are categorized into subgroups and families (Figure 1.3).  The three 
major functional components that facilitate the search for new enolase superfamily 
members are the metal binding ligands at the ends of third, fourth and fifth β-strands. In 
all of the subgroups, the first two metal binding ligands are aspartate and glutamate at the 
ends of third and fourth β-strands, respectively.  The third metal binding ligand, found on 
the fifth β−strand, is aspartate for enolase [18], MLE [19] and MAL [20] subgroups. For 
MR [21] and ManD [22] the third metal binding ligand is a glutamate residue while for 
GlucD [23] it is an asparagine.  
The residues that are responsible for acid-base catalysis and metal binding are the 
main determinants in categorizing enolase superfamily members into subgroups. In case 
of enolases, the catalysis is mediated by a glutamate residue at the end of the second β-
strand and a lysine residue at the end of sixth β-strand. In the MLE subgroup the reaction 
is carried out by lysine residues at the ends of the second and sixth β-strands. In the MR 
subgroup, however, the 1,1-proton transfer and dehydration reactions are carried out by a 
histidine-aspartate dyad at the ends of sixth and seventh β-strands as well as by a variety 
of residues at the end of the second β-strand. Like many of the MR subgroup members, 
enzymes in the GlucD subgroup facilitate catalysis by a histidine-aspartate dyad at the 
ends of seventh and sixth β-strands and by a lysine residue found at the end of the second 
β-strand. 
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Enolase L A L Q E F M I A G N V G D E G G V I V S I E D P F A
MR A V K T K I G Y P G I M V D Y N Q S V T W I E E P T L
MLE V F K L K I G A N S V R V D V N Q Y I D L I E Q P I S
GlucD D F K L K G G V L R I T L D P N G A L A Y A E D P C G
ManD Y K A I R A Q T G H L L H D G H H R L F W L E D C T P
MAL D V L P H A L I N T L H I D V Y G T P L Y I E G P V D
Enolase Q I V A D D L T V A L L L K V N Q I H M V S H R S G E
MR V Q M G E N W L G L A M P D A M K I P M S S H L F Q E
MLE P I M A D E S I E I F A L K I A K N G L Y G G T M L E
GlucD P T A T N M I A T I P L A D P H F W T W G S H S N N H
ManD L A V G E I F N T I D Y I R A T V V R T G C H G A T D
MAL K I V A D E W C N M V Q I K T P D L A Y Q G G T C N E
Enolase T G Q I K T G A P Residues involved in catalysis
MR A H W L E R L D L
MLE T W G T E L F G P Metal binding ligands
GlucD I T A I D T H W I
ManD F G I Q E Y M R H Substrate recognition / subgroup defining
MAL I K P G M G F D E
2nd β-strand 3rd β-strand 4th β-strand
6th β-strand
5th β-strand 6th β-strand 7th β-strand
 
Figure 1.3. Partial multiple sequence alignment of the barrel domain of the six 
founding subgroup members in the enolase superfamily. 
 
1.4.2. Subgroups within the superfamily 
The previous section discussed how the various enolase superfamily members are 
categorized into subgroups based on the identities of key conserved active site residues. 
In this part of the chapter a more detailed analysis of the individual subgroups is 
provided.  
 
1.4.2.1. Enolase subgroup 
The enolase subgroup is the largest within the enolase superfamily, accounting for ~⅓ of 
the superfamily members. The enolase subgroup is also mechanistically the least diverse 
subgroup. To date only one function is known in this subgroup – the enolase reaction by 
which 2-phosphoglycerate is dehydrated to yield phosphoenolpyruvate. However, such 
lack of diversity is not unexpected because of the universality of the glycolysis pathway 
in all kingdoms of life. Enolase catalyzes the ninth reaction in the ten-step pathway and is 
therefore directly responsible for producing one of the key metabolites that drives 
14 
 
oxidative metabolism. Substrate specificity for 2-PGA arises from a complex network of 
interactions, which are made up of residues from both the capping-domain loop structures 
and from the barrel portion of the enzyme. In the enolase from S. cerevisiae the 
interaction partners for the phosphate binding can be found both in the loop structures 
that are formed from both N- and C-terminal parts of the polypeptide as well as residues 
from the barrel domain of the enzyme [24]. Remarkably, the Ala38 and Ser39 that are 
involved in the coordination of the 2-phosphate group of the substrate provide hydrogen 
bonding partners from the backbone amide and carbonyl groups; the same is true for 
Ser375. Ser375, however, provides an additional hydrogen bond donor from the side 
chain hydroxyl group, thus further solidifying the binding. The interaction is tightened by 
the ε-guanidinium group of the Arg374 residue. The guanidinium group of Arg374 is 
coordinated to the side-chain carboxylate group of Glu44 thereby completing the 
framework necessary to bind the 2-PGA substrate (Figure 1.4). 
 
 
Figure 1.4. Stereo view of the binding interactions for 2-PG substrate from the yeast 
enolase structure. The interplay between residues from the loop structures defines 
the substrate specificity for 2-PG. 
 
Glu44 Glu44 
Arg374 Arg374 
Ala39 Ala39 
Ser38 Ser38 
Ser375 Ser375 
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The enolase reaction is initiated by abstraction of the α-proton from 2-PGA, 
mediated by Lys345. The three metal binding ligands – Asp246, Glu295 and Asp320 
coordinate to the essential Mg2+ ion which stabilizes the unstable enediolate intermediate. 
In the course of dehydration, the C3 hydroxyl leaving group accepts a proton that is 
shared by Glu168 and Glu211 to form water. The dehydration reaction, however, is 
reversible. The hydration reaction occurs by activation of water by a network of residues, 
consisting of His159, Glu168 and Glu211, followed by an attack on C3 carbon of the 
PEP substrate. The proton for the C2 carbon is provided by Lys345 residue.   
Not only is the network of interactions that is provided from the loop structures 
unique to the enolase subgroup, but also the active site structure. An additional 
structurally unique feature that distinguishes all other enolase superfamily members from 
the members in this canonical subgroup is the direction of the first two β-strands. In the 
enolase, the first two β−strands lining the interior of the barrel are antiparallel. In other 
subgroups, however, all eight β−strands run in parallel α/β motifs. The overall structure 
for the enolase is therefore αββα(β/α)6-barrel. 
 
1.4.2.2. Mandelate racemase subgroup 
Mandelate racemase (MR) is one of the most extensively studied enzymes in the 
enolase superfamily, especially from the mechanistic point of view. It was known since 
the 1950s that Pseudomonas putida could use both S- and R-mandelate as the sole carbon 
source [25]. Historically MR was the first member to be isolated and characterized in this 
subgroup. Like all other enolase superfamily members, enzymes in the MR subgroup also 
conform to the same three-dimensional structure. Strangely though, the MR subgroup is 
16 
 
among the most functionally diverse subgroups in the enolase superfamily. While the 
enolase subgroup is known to catalyze only the enolase reaction, to date members in the 
MR subgroup can catalyze the racemization of mandelate [26], dehydration of  
L-arabinonate [27], L-tartrate [28], L-fuconate [29], L-talarate/galactarate [30],  
D-galactonate [31], D-gluconate [32] and L-rhamnonate [33] (Figure 1.5).  
Members of the MR subgroup catalyze the acid-base chemistry by a histidine-
aspartate dyad or via a lysine residue at the end of the second β-strand. In the case of 
acid-sugar dehydratases, the reaction is usually completed by anti elimination of water, 
with galactarate and L-rhamnonate dehydratases [30, 33] being the exception with syn 
dehydrations. The dehydration reaction is stereospecific. For MR, the lysine residue at 
the end of the second β-strand initiates the proton-transfer reaction for (S)-mandelate and 
His-Asp dyad for (R)-mandelate as established for Pseudomonas putida MR. Although 
most of the first shell active site residues are conserved in the MR subgroup, the residues 
at the end of the second β-strand vary. Commonly, residues pointing into the active from 
the second β-strand form a Lys-x-Lys motif, but other combinations are known such as 
Lys-x-(Arg, His, Asp, Tyr, x). The variability contributed from the second β-strand is 
also a means by which candidates for novel substrate specificities are identified in the 
MR subgroup. The major contributors with respect to substrate specificity, however, can 
be found in the capping domain as is the case for the rest of the enolase superfamily. 
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Figure 1.5. Reactions in the MR subgroup. The stereochemical course of the 
reaction is known for all but L-arabinonate dehydratase. 
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1.4.2.3. Muconate lactonizing enzyme subgroup 
Muconate lactonizing enzyme (MLE) subgroup is the most mechanistically 
diverse entity within the enolase superfamily. Reactions catalyzed by the various 
members in the MLE subgroup include cycloisomerization, dehydration, racemization, 
and epimerization (Figure 1.6). 
 
 
Figure 1.6. Canonical reactions in the MLE subgroup. 
 
To date two classes of MLEs are known which catalyze the ring opening reaction 
of muconolactone and the cycloisomerization reaction of cis,cis-muconate. Class I MLEs, 
which includes the canonical MLE from Pseudomonas putida, catalyze syn-
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cycloisomerization [19]; the class II MLEs, which include the MLE from Mycobacterium 
smegmatis, catalyze anti-cycloisomerization [34]. Another interesting and growing 
family of proteins within the MLE subgroup is the dipeptide epimerases. Thus far, two 
distinct classes of L-Ala-D/L-Glu epimerases are known, as well as an L-Ala-D/L-Phe 
epimerase [14] and a D-Ala-D/L-Ala epimerase [Chapter 2]. Members in the MLE 
subgroup have also evolved the ability to racemize N-succinylamino acids [13].  
The largest and most divergent family of proteins within the MLE subgroup are the 
various o-succinylbenzoate synthases (OSBS) which catalyze the syn-dehydration of  2-
succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate (SHCHC) to form o-
succinylbenzoate (OSB) in the menaquinone biosynthetic pathway [35]. The large 
number of OSBSs is not surprising, however, due to the universality of menaquinone as 
an electron acceptor in bacterial microbial respiration.  
Catalysis in the MLE subgroup is mediated by two lysine residues at the ends of 
the second and sixth β-strands. Unlike the MR subgroup, where the histidine-aspartate 
dyad can exclusively act both as the acid- and base-catalyst, in the MLE subgroup both 
lysine residues are necessary to complete the variety of reactions. In the MLE subgroup, 
specificity for the type of substrate is to some extent determined by the residues at the 
end of the eighth β-strand. 
 
1.4.2.4. Additional subgroups in the enolase superfamily 
Three additional small subgroups in the enolase superfamily have been identified 
thus far: β-methylaspartate ammonia lyase (MAL) [20], D-glucarate dehydratase (GlucD) 
[36] and D-mannonate dehydratase (ManD) [22] (Figure 1.7). The two latter subgroups 
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were initially classified as being members of the MR subgroup, but were later reclassified 
into separate subgroups because of structural dissimilarities in the active site architecture. 
MAL catalyzes the reversible β-elimination reaction of ammonia from β-
methylaspartate to give mesaconic acid utilizing a lysine residue at the end of the sixth β-
strand. Like the enolase reaction, MAL catalyzed β-elimination is reversible, but MAL 
can also utilize several derivatives of mesaconic acid in the reverse reaction. In the 
reverse reaction ammonia is added to mesaconic acid in a stereo- and regioselective 
manner to give several homochiral substituted aspartic acids.  
GlucD is a vital enzyme for Escherichia coli which enables its growth on D-
glucarate as the sole carbon source. GlucD and its cousin, glucarate dehydratase related 
protein (GlucDRP), are the only two members in this divergent clade. The major 
difference between the active site of the GlucD subgroup and all others in the enolase 
superfamily is identities of the three metal binding ligands. Traditionally, the catalytically 
essential magnesium ion is coordinated to the side chain carboxylate groups of either 
aspartate or glutamate residues. In the case of the GlucD subgroup, however, the third 
metal binding ligand at the end of the fifth β−strand is an asparagine, and the electrostatic 
interaction to the magnesium ion is facilitated through the side chain carbonyl group of 
that residue. Another unique feature of GlucD is the ability to catalyze the epimerization 
of D-glucarate and L-idarate (an unnatural compound). It is well-established that 
members of the MR subgroup can abstract the α-proton of a carboxylic acid compound 
that closely resembles its natural substrate without proceeding through dehydration or 
epimerization [29]. GlucD, however, is the only example where there is enough 
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flexibility in the active site to allow the enolate anion intermediate to utilize an alternate 
pathway and produce the 2-epimer of the starting material. 
The third subgroup contains enzymes with ManD activity. This subgroup is an 
example of how classification of enzymes into subgroups based on sequence alignment 
alone may not be sufficiently accurate. ManD was initially classified as a member of the 
MR subgroup, but as the structural information emerged, it became clear that the active 
site architecture of this enzyme is unique and the residues lining the active site are 
different from what was predicted based on sequence alignment. The dehydration 
reaction of D-mannonate is initiated by the proton abstraction via an unusual tyrosine-
arginine dyad general base. Protonation of the hydroxyl leaving group is mediated 
through a histidine or a tyrosine general acid.  
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Figure 1.7. Reactions in the enolase, GlucD, ManD and MAL subgroups. 
 
The overall structure of ManD is a (β/α)8 barrel with an unusual capping domain 
that is lacking the loop structures commonly found in the other previously characterized 
subgroups. Both catalytically active residues extend from the C-terminal stretch of the 
second β-strand which is another feature unique to the ManD subgroup. 
The large number of enzymes and the mechanistic diversity in the enolase 
superfamily are some of the key features that make its study attractive (Figure 1.8). The 
enolase superfamily is a paradigm of natural enzyme evolution which has served as a 
model system for testing genomic enzymological techniques. 
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Figure 1.8. Sequence similarity network of the various subgroups in the enolase 
superfamily. Each dot represents an enolase superfamily member. The sequences 
are clustered together based on the blast expectation value. If the sequences are 
within a certain threshold e-value, they are connected through a line but if the 
threshold value is exceeded, a unique cluster is formed.  
 
blastp e-50 
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CHAPTER 2: FUCTIOAL ASSIGMET OF THE L-ALA-D/L-GLU 
EPIMERASE FROM Bacteroides thetaiotaomicron (BT1313) AD D-ALA-D/L-
ALA EPIMERASE FROM Cytophaga hutchinsonii (CHU2140). 
2.1. Background information 
2.1.1. Detailed analysis of the MLE subgroup 
As described in the previous chapter, the MLE subgroup is mechanistically one of 
the most diverse subgroups in the enolase superfamily. At the moment, the MLE 
subgroup contains ~1600 sequences. In this section a more detailed overview of the MLE 
subgroup will be provided. 
 
2.1.1.1. MLE family 
The cycloisomerization of cis,cis-muconate in the MLE subgroup is achieved by a 
Lys residue at the C-terminal end of the 2nd β-strand, with one of the C5-protons of the 
(4S)-muconolactone product derived from solvent [37].  The two classes of MLEs within 
this subgroup achieve catalysis via two distinct stereochemical strategies. The archetypal 
MLE from Pseudomonas putida is the structural paradigm for the subgroup and catalyzes 
the syn-cycloisomerization to produce (4S)-muconolactone with the 5-pro-R hydrogen 
derived from the solvent [19, 37]. The MLEs that catalyze syn-cycloisomerization are 
designated MLE-1. The second type of MLEs, designated MLE-2, catalyze anti-
cycloisomerization of cis,cis-muconate. In the MLE-2, the (4S)-muconolactone product is 
produced with the 5-pro-S proton derived from solvent (Figure 2.1). The Lys residue at 
the end of the 2nd β-strand serves as the general acid for the cycloisomerization reaction. 
Our lab recently characterized the MLE-2 from Mycobacterium smegmatis for which an 
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X-ray crystal structure also was solved. In the same work, a crystal structure was solved 
for an ortholog of the P. putida MLE-1 from P. fluorescens [34]. Although the 
unliganded P. putida MLE-1 structure had been known, a liganded structure had not been 
solved for that enzyme, leaving the structure-function relationships uncertain. 
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Figure 2.1. The general reaction mechanism for the MLE-1 (bottom right) and 
MLE-2 enzymes (top right). A solvent derived hydrogen is incorporated into the 5-
pro-S position in case of MLE-2 and in the 5-pro-R position in the case of MLE-1. 
 
The structural basis for the stereochemical discrimination between the two types of MLEs 
is provided by the active site geometries which are determined by the loops covering the 
active site cavity. The 20s loops in both types of MLEs are the same length but contain 
divergent sequences. Additionally the 50s loops, which are also divergent in sequence, 
differ by two amino acids in length (Figure 2.2).  
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Pseudomonas fluorescens  MLE-1 M S L H A S A I E S I E T I I V D L P T I R P H K L A M H T M Q N Q T L V L I R L R C A D G I E G L G E S T T I G G L A
Mycobacterium smegmatis MLE-2 - - - - - M K I V A I G A I P F S I P Y T K P L R F A S G E V H A A E H V L V R V H T D D G I V G V A E A P P R P F - -
Pseudomonas fluorescens  MLE-1 Y G N E S P D S I K T N I D R F V A P L L I G Q D A - S N I N A A M L R L E Q S I R G N T F A K S G I E S A L L D A Q G
Mycobacterium smegmatis MLE-2 T Y G E T Q T G I V A V I E Q Y F A P A L I G L T L T E R E V A H T R M A R T V G - - N P T A K A A I D M A M W D A L G
Pseudomonas fluorescens MLE-1 K R L G L P V S E L L G G R V R D A L P V A W T L A S G D T A K D I A E A Q K M L D L R R H R I F K L K I G A G E V D R
Mycobacterium smegmatis  MLE-2 Q S L R L S V S E M L G G - Y T D R M R V S H M L G F D D P V K M V A E A E R I R E T Y G I N T F K V K V G R R P V Q L
Pseudomonas fluorescens MLE-1 D L A H V I A I K K A L G D S A S V R V D V N Q A W D E A V A L R A C R I L G G N G I D L I E Q P I S R N N R A G M V R
Mycobacterium smegmatis  MLE-2 D T A V V R A L R E R F G D A I E L Y V D G N R G W S A A E S L R A M R E M A D L D L L F A E E L C P A D D V L S R R R
Pseudomonas fluorescens MLE-1 L N A S S P A P I M A D E S I E C V E D A F N L A R E G A A S V F A L K I A K N G G P R A T L R T A A I A E A A G I G L
Mycobacterium smegmatis  MLE-2 L V G Q L D M P F I A D E S V P T P A D V T R E V L G G S A T A I S I K T A R T G - F T G S T R V H H L A E G L G L D M
Pseudomonas fluorescens MLE-1 Y G G T M L E G G I G T L A S A H A F L T L N K L S W D T E L F G - P L L L T E D I L A E P P V Y R D F H L H V S K A P
Mycobacterium smegmatis  MLE-2 V M G N Q I D G Q I G T A C T V S F G T A F E R T S R H A G E L S N F L D M S D D L L T V P L Q I S D G Q L H R R P G P
Pseudomonas fluorescens MLE-1 G L G L S L D E E R L A F F R R E G H H H H H H
Mycobacterium smegmatis MLE-2 G L G I E I D P D K L A H Y R T D N - - - - - -
 
Figure 2.2. Sequence alignment of MLE-1 and MLE-2. Red: specificity; blue: metal 
binding; green: catalysis. 
 
From the X-ray structures for both classes of MLEs, the enzymes use a different 
structural strategy for binding the substrate which results in the two distinct 
stereochemical courses of cycloisomerization. The carbonyl oxygen of the (4S)-
muconolactone product in the MLE-1 structure is coordinated to His 24 in the 20s loop 
(Figure 2.3). In the Mycobacterium MLE-2, Gln 294 at the end of the seventh β-strand of 
the barrel domain forms a hydrogen bond with the carbonyl oxygen of the product, one of 
the key determinants that results in anti-cycloisomerization (Figure 2.3).  
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Figure 2.3. Left panel: MLE-1 active site structure from Pseudomonas fluorescens. 
Right panel: MLE-2 active site structure from Mycobacterium smegmatis. 
 
2.1.1.2. OSBS families 
OSBS catalyzes the syn-dehydration of 2-succinyl-6-hydroxy-2,4-
cyclohexadiene-1-carboxylate (SHCHC) to yield o-succinylbenzoate (OSB), an 
intermediate in the menaquinone biosynthesis pathway. The OSBS family includes 
several subfamilies of highly diverged enzymes. The sequence identities relating the 
different OSBSs can be as low as 15% [38]. The OSBS function likely has evolved 
multiple times during the course of evolution [38]. That proposal has been made not only 
because of the low sequence identities between the various OSBSs but also because of 
the abundance of organisms that use menaquinone as an electron acceptor in their 
anaerobic respiration. Despite the divergence in sequences, the reaction mechanism and 
the stereochemical course of the reaction, is conserved in all OSBSs (Figure 2.4). 
 
Gln 294 
His 24 
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Figure 2.4. General reaction mechanism of o-succinylbenzoate synthase. 
 
The reaction is initiated by abstraction of a α-proton by a Lys general base catalyst at the 
end of the 2nd β-strand. The reaction proceeds through an enediolate intermediate 
stabilized by the conserved Mg2+ ion with protonation of the hydroxyl leaving group by 
the conjugate acid of the same Lys residue. Although the sequences of the various OSBSs 
are divergent, the geometry of the active site is conserved. 
 
2.1.1.3. AEE family 
The founding member in this family catalyzes the epimerization of L-Ala-D/L-
Glu, a component of the bacterial peptidoglycan [39] and was first identified in E. coli. 
Epimerization is achieved via the Lys residues at the ends of the 2nd and the 6th β-strands. 
The Lys residues can act as either general acid or base catalysts, depending on the 
stereochemical course of the reaction. The E. coli AEE is an example of promiscuity in 
the enolase superfamily, because it is capable of epimerizing other dipeptides that contain 
L-Ala in the N-terminal position of the substrate. The substrate specificity defining 
element for the C-terminal portion of the L-Ala-D/L-Glu substrate is Arg21 of the 20s 
loop. The guanidinium group hydrogen bonds to the γ-carboxylate group of the Glu 
moiety, therefore establishes the specificity for that substrate. The specificity for the L-
Ala residue is determined by a hydrophobic pocket that forms in the back portion of the 
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active site. Although no liganded structure is available for the AEE from E. coli, 
substrate-enzyme interactions can be inferred from a comparison to the liganded structure 
of the B. subtilis AEE. Although the AEE subgroup is not as divergent in sequence as the 
OSBS family, most members share as little as 30% sequence identity. The E. coli and B. 
subtilis AEEs are about 35% identical; the active sites, however, are conserved. Several 
additional dipeptide epimerases have been identified since the discovery of the AEEs. An 
L-Ala-D/L-Phe epimerase from Thermotoga maritima [14] and an L-Lys-D/L-Arg 
epimerase from Methylococcus capsulatus (Sakai, unpublished results) were recently 
identified. Dipeptide epimerases that utilize L-Ala-D/L-Glu and D-Ala-D/L-Ala will be 
discussed in detail in later portions of this chapter. The key feature that distinguishes 
dipeptide epimerases (e.g. the AEE family members) from other MLE subgroup members 
is the DxD motif at the end of the 8th β-strand. Substrate specificity defining elements can 
be found in the 20s and 50s loops’ sequences. 
 
2.1.1.4. &SAR family 
The NSAR family contains enzymes involved in a pathway that irreversibly 
converts D-amino acids into L-amino acids [40]. One of the first enzymes identified in 
this family (Amycolatopsis NAAAR/OSBS) also catalyzes a promiscuous OSBS reaction 
[41].  It subsequently became clear that orthologues of this enzyme effectively catalyze 
the racemization of &-succinylated amino acids. It was determined that these enzymes 
were in a pathway, that would step-wise &-succinylate a D-amino acid, racemize the &-
succinyl-D-amino acid, followed by the cleavage of the &-succinyl group to release the 
L-amino acid and succinate. For the Amycolatopsis enzyme, racemization of the &-
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succinylamino acids proceeds about 100-fold faster than the &-acylamino acids which is 
an additional reason for the establishment of the &-succinylamino acid racemase (NSAR) 
family [40]. 
 
2.1.2. Prediction of dipeptide epimerases of novel substrate specificities 
The historical method for finding new enolase superfamily members of novel 
substrate specificities has been to look for differences in the regions of protein sequence 
that are believed to be involved in substrate specificity. This, however, is becoming 
increasingly more difficult and impractical as the protein sequence databases are 
expanding exponentially in size. There are, however, some key characteristics that allow 
for classification of divergent sequences into enzyme subgroups and families. For the 
dipeptide epimerases, the first criterion is the presence of a KxK motif at the end of the 
2nd β-strand and a lysine residue at the end of the 6th β-strand; this allows the sequences 
to be placed in the MLE subgroup. The second criterion is the presence of a conserved 
DxD motif at the end of the 8th β-strand which as described earlier is the recognition 
sequence for the α-ammonium group of a dipeptide substrate. These enzyme sequences 
can then be subjected to in silico homology modeling and virtual screening of dipeptide 
substrates [13, 14]. This novel approach reduces the number of substrates that need to be 
assayed experimentally. Due to the polyprotic nature of the Lys, acid-base catalysts, the 
product is equilibrated with solvent-derived hydrogen atoms. The enzyme is subjected to 
a screen in D2O buffer with a selected library of dipeptides (e.g. L-Ala-L-Xxx, where 
Xxx stands for any of the canonical 20 α-amino acids). Subsequently, the deuterium atom 
incorporation into the product molecule is detected via electrospray ionization mass-
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spectrometry (ESI-MS) [13, 39]. The “fast” substrates are then kinetically characterized 
via polarimetry or NMR. In addition to the enzymes characterized in later parts of this 
chapter, the described methodology has been utilized successfully to identify an L-Ala-
D/L-Phe epimerase [14] and a divergent NSAR [13]. 
 
2.2. Materials and methods 
2.2.1. Cloning genes 
2.2.1.1. Cloning of CHU2140 
The gene encoding a putative dipeptide epimerase (gi:110638536) from 
Cytophaga hutchinsonii (ATCC 33406) was amplified from genomic DNA with the 
following oligonucleotide primers from the complement strand: 
 
5'-GTCTTTTTTTCGTATAGGTGTATTAATATGATTATAACACAGG-3' 
5'-CACAAACTCGAGGCGCTCAGTTTATGCATATTTTTTC-3' 
 
The primer in the forward direction was designed with an AseI endonuclease cleavage 
site (in bold) which would provide complementary overhang to an &deI restricted 
plasmid in the 5’ end of the encoding strand. This was done because the gene contains 
both an &deI and a BamHI restriction site within the coding region of the DNA sequence. 
The reverse primer was designed with an XhoI restriction site (in bold). Both restriction 
sites were designed to facilitate the multiple cloning site of pET vectors (Novagen). The 
gene was amplified via polymerase chain reaction (PCR) using Platinum® Pfx DNA 
polymerase (Invitrogen). The PCR amplification mixture (100 µL) contained 0.5 µL of 
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100 ng/µL template DNA, 2 µL of 50 mM MgSO4, 0.5 µL of 2.5 units/µL Platinum® Pfx 
DNA polymerase, 10 µL of 10× Pfx amplification buffer, 10 µL of 10× enhancer buffer, 
2 µL of 20 mM dNTP mix, 2 µL of each 20 µM forward and reverse primer, and 71 µL 
of ddH2O. The PCR was performed on a PTC-200 Peltier Thermal Cycler (MJ Research) 
by the following program: 94 °C for 3 min followed by 40 cycles of 94 °C for 1 min, 65 
°C for 1.25 min, 68 °C for 3 min; the final extension was 10 min at 68 °C. The size of the 
PCR product was analyzed on a 1% agarose gel, extracted using the Qiagen gel 
extraction protocol (Qiagen, Inc), and eluted with 40 mL ddH2O. The purified PCR 
product was digested with appropriate restriction enzymes as were engineered into the 5’ 
and 3’ primers, using the Qiagen PCR purification protocol to remove residual buffer and 
restriction enzyme between digests. The resulting doubly cut insert was gel purified again 
and ligated into prepared pET-17b expression vector (Novagen) using T4 DNA ligase 
(Invitrogen) in a reaction held at 16 °C for at least 16 hours. The excess salt in the 
ligation mixture was removed by dialysis against ddH2O using a 0.025 µm filter 
(Millipore Type VSWP) for a minimum of 15 minutes before being electroporated (1.8V, 
25 µFD, 200 Ω) into XL1Blue cells. Cells were plated onto LB agar plates in the 
presence of 100 µg/mL ampicillin and incubated overnight at 37 °C. The colonies were 
screened with PCR for insert-containing plasmids utilizing the following primers: 
 
T7Pro 5’–CCCGCGAAATTAATACGACTCACTATAGGGG–3’ 
T7Term 5’–CAAGGGGTTATGCTAGTTATTGCTCAGCGG–3’ 
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The primers were designed to anneal to the T7 promoter and terminator regions within 
the pET vectors, such that the plasmids positive for insert were indicated by a ~300 bp 
increase in original insert size, and vectors negative for insert resulted in a ~300 bp PCR 
product.  The colony PCR amplification mixture (100 µL) contained 10 µL of colony 
suspension, 3 µL of 50 mM MgCl2, 0.2 µL of 5 units/µL Taq DNA polymerase 
(Invitrogen), 10 µL of 10×PCR amplification buffer, 1 µL of 20 mM dNTP mix, 2.5 µL 
of each 20 µM T7Pro and T7Term primers, and 71 µL of ddH2O. The PCR was 
performed on a PTC-200 Peltier Thermal Cycler by the following program: 95 °C for 5 
min followed by 40 cycles of 95 °C for 1.5 min, 50 °C for 1 min, 72 °C for 5 min; the 
final extension was 10 min at 72 °C. The PCR mixtures were analyzed on a 1% agarose 
gel. Insert containing vectors were submitted for sequencing for gene verification to the 
University of Illinois Core Sequencing Facility. 
 
2.2.1.2. Cloning of a truncation mutant of CHU2140 
A primer was designed for a C-terminally truncated variant of the CHU2140 
enzyme. The C-terminal truncation was chosen as a result of poor solubility 
characteristics of the wild-type enzyme and to eliminate a homologous C-terminal region 
that is disordered in the B. subtilis AEE crystal structure. For convenience, the same 
forward primer was used for amplification as in the previous section. The primer 
sequence in the reverse direction was designed with a UGA stop codon (underlined) and 
an XhoI cleavage site (bold):  
5' -CCAGGCTCGAGAGTCAATCCTTCTGGTAACCGG-3'. The truncated gene 
variant was amplified from the CHU2140 containing pET-17b plasmid DNA as described 
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in the previous section for the full-length gene. The truncated variant of CHU2140 was 
ligated into the prepared pET-17b vector as described earlier. 
 
2.2.1.3. Cloning of BT1313 
The gene encoding a putative dipeptide epimerase (gi:29338620) from 
Bacteroides thetaiotaomicron strain VPI-5482 was amplified from the genomic DNA 
(kindly provided by Prof. Abigail Salyers) with the following oligonucleotide primers 
from the complement strand: 
 
5’-CATATTAATAAATATGGTATAGGGGGACATATGAAAATGACTTTTTTCCC-
3’ 
5’-CATTCTCGAGGATCAGATTTTCATGACACCAATTCCGGGTAAGTC -3’ 
 
 
The primers were designed with &deI (forward) and XhoI (reverse) endonuclease 
cleavage sites (bold). Due to a possible error in the NCBI non-redundant database, the 
forward primer was designed to shorten the N-terminal portion of the encoding region by 
45 amino acids. This assumption was made on the basis of a multiple sequence alignment 
of the enzyme with its homologues from Bacteroides fragilis strains and a number of 
other divergent dipeptide epimerases that are missing this long N-terminal stretch. The 
gene was amplified as described earlier. The gene was ligated into prepared pET-15b and 
pET-17b vectors as described earlier. 
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2.2.1.4. Cloning of BT1314 dipeptidase 
The gene encoding a putative dipeptidase (gi:29338621) from B. thetaiotaomicron 
strain VPI-5482 was amplified from the genomic DNA with the following 
oligonucleotide primers:  
 
5’-CTTTGCTATCATTAAATCATGATCATATGAAGAAAAATATCC-3’ 
5’-CATTTGTTTAATGGACTCGAGTTAGTGATGTAGATAATAG-3’ 
 
The primers were designed with &deI (forward) and XhoI (reverse) endonuclease 
cleavage sites (bold). The gene was amplified and ligated into prepared pET-15b, pET-
17b, pDMS-1a and pKK-His10 vectors as described earlier. 
 
2.2.1.5. Cloning of BF2763 
The gene encoding BF2736 (gi:60493669), an ortholog of BT1313, from 
Bacteroides fragilis strain NCTC 9343 was amplified form the genomic DNA (kindly 
provided by Prof. Abigail Salyers) with the following oligonucleotide primers:  
 
5'-CGATCAATCAACTCGGCCTGGGGGCACATATGAAATTGCG-3'    
5'-GTTTACTCGAGTTCATATTTTAACCACCCCGATCCCCGGAAG-3' 
 
The primers were designed with &deI (forward) and XhoI (reverse) endonuclease 
cleavage sites (bold). The gene was amplified and cloned into the prepared pET vectors 
as before. 
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2.2.2. Expression and purification of proteins 
The expression plasmids containing the gene of interest were transformed into E. 
coli BL21 (DE3). Unless otherwise indicated, the transformed BL21 cells were grown 
overnight at 20 °C, 25 °C and 37 °C in Luria-Bertani (LB) media for expression 
screening. 
 
2.2.2.1. Expression and purification of CHU2140 
CHU2140 was screened for expression; and growth at 25 °C for 72 hours yielded 
the best results in terms of soluble protein expressed per 2 L of media.  
 
2.2.2.1.1. Purification of CHU2140 
For a typical protein purification, the cells were grown in 4L of LB media at 25 
°C for 3 days in the presence of 100 µg/mL of ampicillin. The cells were harvested by 
centrifugation and resuspended in 60 mL of 20 mM Hepes-HCl, pH 8.35, containing 5 
mM MgCl2. The suspension was then lysed on ice using a Fisher Scientific 550 Sonic 
Dismembrator; cell lysate was centrifuged to pellet insoluble debris. The supernatant was 
applied to a DEAE-Sepharose FF column (2.5 cm × 50 cm, GE Healthcare) and eluted 
with a linear gradient (1600 mL) of 0 to 1 M NaCl buffered with 20 mM Hepes-HCl, pH 
8.35, containing 5 mM MgCl2. Fractions containing CHU2140, as determined by SDS-
PAGE,  were applied to Phenyl Sepharose 6FF column in 0.5 M (NH4)2SO4 and 20 mM 
Hepes-HCl, pH 7.9, (1.6 x 20 cm, GE Healthcare) for further purification. The column 
was washed with 100 mL of 0.5 M (NH4)2SO4 in 20 mM Hepes-HCl, pH 7.9, and eluted 
with a linear gradient of 0.5 to 0 M (NH4)2SO4 (600 mL) containing 20 mM Hepes-HCl, 
37 
 
pH 7.9, and 5 mM MgCl2. The protein was dialyzed against 50 mM Hepes-HCl, pH 7.9, 
containing 100 mM NaCl and 5 mM MgCl2 for storage using the 10,000 Da molecular 
weight cut-off dialysis tubing (Spectrum). 
 
2.2.2.1.2. Analytical size-exclusion chromatography for CHU2140 
The molecular weight of the protein was determined by the ProtParam tool 
(EXPASY) to be 40,310.6 Da. The biologicial unit of the protein was determined to be a 
monomer based on analytical gel filtration chromatography. Although majority of the 
enzyme seems to be in a monomeric state, the minor “hump” left of the major peak on the 
chromatogram suggests for the presence of a dimeric form of CHU2140 (Figure 2.5). 
 
 
Figure 2.5. Chromatogram from the analytical size-exclusion chromatography of 
CHU2140. Molecular weight standard trace in blue, CHU2140 trace in red. 
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2.2.2.1.3. ESI-MS for CHU2140 
Because of the lack of an affinity tag, the molecular weight of the protein was 
verified via mass spectrometry. Electrospray ionization mass spectrometry was carried 
out in ES+ mode utilizing a Micromass Quattro-II quadrupole-hexapole-quadrupole mass 
spectrometer. The molecular weight of the protein was calculated with the Maximum 
Entropy function of the Waters MassLynx software. The experimentally determined 
molecular weight of 40,313.0 is in good agreement with the theoretical weight of 
40,310.6 Da (Figure 2.6). 
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Figure 2.6. ESI-MS of CHU2140. Top panel: detected charged states of the enzyme; 
bottom panel: experimental calculated molecular weight of the enzyme. 
 
2.2.2.1.4. Expression of truncated CHU2140 
Due to initial difficulties with protein stability, a C-terminal truncation mutant 
was generated to tackle the issue. The truncation mutant, however, yielded no soluble 
protein and only inclusion bodies at 20 °C, 25 °C, and 37 °C in LB media in the presence 
of 100 µg/mL of ampicillin. Any further work on this mutant was terminated. 
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2.2.2.2.  Expression and purification of BT1313 
 E. coli BL21 (DE3) cells were transformed with BT1313 in pET vectors. 
Expression screening was carried out as described in the prior section. The protein 
expressed well using both pET-15b (6 His affinity tag) and pET-17b (no tag) expression 
vectors. The 6 histidine affinity tag, however, could not be removed. Although initial 
screening for dipeptide epimerase activity was done with affinity tagged BT1313, all later 
experimentation was performed with the enzyme expressed from pET-17b vector. In 
addition to utilizing the BL21 (DE3) strain, a batch of BT1313 was purified from an AEE 
knock-out strain of E. coli K-12 previously generated in the lab.  The AEE knock-out 
strain was first transformed with the pTARA plasmid that encodes the T7 RNA 
polymerase under the regulation of TAC promoter [42]. The pTARA containing knock-
out strain was then transformed with BT1313 in pET-17b and incubated at 25 °C for 48 
hours without induction in LB media in the presence of 100 µg/mL of ampicillin and 34 
µg/mL of chloramphenicol (the latter is required for pTARA). Typically, when BT1313 
was expressed in E. coli BL21 (DE3), the same incubation time and temperature were 
used for optimal protein expression. 
 
2.2.2.2.1. Purification of BT1313 
The purification procedure for BT1313 resembles very closely that used for 
CHU2140. The cells were grown and harvested as described above. The cells were 
suspended in 20 mM Tris-HCl, pH 8.0, containing 5 mM MgCl2 and lysed as described 
above. The insoluble cell debris was removed via centrifugation. The supernatant was 
applied to a DEAE-Sepharose FF column (2.5 cm × 50 cm, GE Healthcare) and eluted 
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with a linear gradient (1600 mL) of 0 to 1 M NaCl buffered with 20 mM Tris-HCl, pH 
8.0, containing 5 mM MgCl2. Fractions containing BT1313, as determined by SDS-
PAGE, were further purified over Phenyl Sepharose column as described above. The pure 
protein was dialyzed against 50 mM Tris-HCl, pH 7.9, containing 100 mM NaCl and 5 
mM MgCl2 for storage. 
 
2.2.2.2.2. Analytical size-exclusion chromatography for BT1313 
The biologicial unit of the protein was determined to be a monomer based on 
analytical gel filtration chromatography. As observed for CHU2140, however, in addition 
to the major monomeric peak, a smaller “hump” indicative of a dimeric state of BT1313 
was present as well (Figure 2.7). 
 
Figure 2.7. Chromatogram from the analytical size-exclusion chromatography of 
BT1313. ote the “hump” left to the major 44 kDa peak, indicative of a dimeric 
state. 
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2.2.2.2.3. ESI-MS of BT1313 
The mass-spectroscopic data were acquired as described previously for 
CHU2140. The experimental molecular weight was determined to be 37,495.0 Da which 
is in good agreement with the theoretical molecular weight of 37,493.4 Da (Figure 2.8). 
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Figure 2.8. ESI-MS of BT1313. Top panel: detected charged states of the enzyme; 
bottom panel: experimental calculated molecular weight of the enzyme. 
 
2.2.2.2.4. Purification of SeMet labeled BT1313 
Selenomethionine-labeled BT1313 was produced as follows. 2 L of tap water 
containing 33 g of K2HPO4x3H2O, 3 g of KH2PO4, and 2 g of (NH4)2SO4 was autoclaved. 
60 mL of 30% glucose was added. Additionally, the medium contained 20 mL of a sterile 
filtered solution of 0.4 g MgSO4x7H2O, 20 mg of CaCl2x2H2O, 2 mL of 50 µg/mL of 
FeSO4x7H2O, 0.1 g of thiamine, and 0.2 g of ampicillin. A 5 mL overnight culture was 
used to inoculate the 2 L culture of the prepared medium. The culture was grown at 37 °C 
to an OD600 of 0.6. At this stage, a 40 mL methionine-suppression solution was added 
containing 200 mg of L-Lysine, 200 mg of L-Threonine, 200 mg of L-Phenylalanine, 100  
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mg of L-Leucine, 100 mg of L-Isoleucine, and 100 mg L-Valine. The culture was 
returned to shaking at 37 °C for 30 minutes. 0.1 g of SeMet was added to the culture with 
IPTG to the final concentration of 0.5 mM. The culture was returned to shaking at 25 °C 
for 48 hours. The cells were harvested by centrifugation and the same purification 
procedure was followed as described for unlabeled BT1313, with the addition of 2 mM 
β-mercaptoethanol to the sonication buffer and loading buffers for each column 
purification step. 
 
2.2.2.2.5. ESI-MS of SeMet-BT1313 
Due to the unusual nature of BT1313, extended incubation time was required for 
the protein expression. The extended expression time likely contributed to SeMet 
depletion from the growth medium, which resulted in ~50% SeMet labeling. The mass-
spectrum contained four different species: native BT1313 (expected: 37,493; observed: 
37,490), SeMet-BT1313 (expected: 38,196; observed: 38,200) and β-mercaptoethanol 
adducts of both species (expected: +76 Da; observed: +76 Da) (Figure 2.9).  
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New try at SeMet BTs protein for almo. This is combined fractions from Phenyl Sepharose column. about 2mg/ml
m/z
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Figure 2.9. ESI-MS of SeMet-BT1313. Top panel: detected charged states of the 
enzyme; bottom panel: experimental calculated molecular weights of the multiple 
enzyme species. 
 
2.2.2.3. Expression and purification of BF2763 
BF2763 was transformed into E. coli BL21 (DE3) and screened for expression as 
described in earlier sections. The majority of the protein, however, was expressed as 
inclusion bodies. No protein corresponding to the size of BF2763 was detected in the 
soluble fraction on SDS-PAGE. Although the expression was poor, it was decided to 
proceed to “fish out” the potentially soluble protein using histidine-tag affinity 
chromatography.  
 
2.2.2.3.1. Purification of BF2763 
BF2763 was expressed in E. coli BL21 (DE3) using the pET-15b vector. The cells 
were harvested via centrifugation and suspended in Binding buffer. The buffers utilized 
in the His-tag affinity purification are listed in Table 2.1.  
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Table 2.1. Buffers utilized for His-tag affinity chromatography. 
 
The cells were lysed by means of sonication as described earlier. The insoluble cell 
debris was removed by centrifugation. The cleared lysate was loaded onto a Chelating 
Sepharose Fast Flow column (1.6 cm x 40 cm, GE Healthcare). The column was 
subsequently washed with a mix of 5% Elute and 95% Wash buffer. The protein was 
eluted with Strip buffer in a total volume of 400 mL. Ten mL fractions were collected. As 
determined by SDS-PAGE, fractions containing BF2763 were dialyzed against 20 mM 
Tris-HCl, pH 7.9, containing 100 mM NaCl and 5 mM MgCl2 for storage. The purified 
Buffer Contents 
Binding buffer 5 mM Imidazole 
500 mM NaCl 
20 mM Tris-HCl, pH 7.9 
5 mM MgCl2 
Wash buffer 60 mM Imidazole 
500 mM NaCl 
20 mM Tris-HCl, pH 7.9 
5 mM MgCl2 
Elute buffer 1 M Imidazole 
500 mM NaCl 
20 mM Tris-HCl, pH 7.9 
5 mM MgCl2 
Strip buffer 100 mM EDTA 
500 mM NaCl 
20 mM Tris-HCl, pH 7.9 
Charge buffer 50 mM NiSO4 
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protein, however, was not homogenous and on an SDS-PAGE, contained multiple bands, 
including the band with the desired molecular weight.  
 
2.2.3. Solution phase synthesis of dipeptide substrates 
2.2.3.1. Synthesis of D-Ala-L-Val 
A typical reaction mixture for the synthesis of D-Ala-L-Val was set up in 14 mL 
of CHCl3 and contained 2 mmoles of Boc-D-Ala-OH and H-Val-OMe. For coupling, 4 
mmoles of 1-hydroxybeonzotriazole (HOBt) and N,N’-diisopropylcarbodiimide were 
added and placed on a shaker for overnight incubation at room temperature (RT). The 
mixture was filtered and rotaryevaporated to a syrup and washed 3 times with chilled 
acetone; the white precipitate was filtered and discarded. Remaining pale yellow solution 
was applied to a silica column (2 cm x 30 cm) and eluted with 125 mL of acetone. 
Fractions were spotted on a TLC and visualized for the presence of Boc-D-Ala-L-Val-
OMe with ninhydrin spray. Fractions containing the protected dipeptide were 
rotaryevaporated to a syrupy substance. The protective groups were removed in two 
steps: incubation with 1:1 mix of 2 N NaOH and CH3OH for 2 hours at RT, 
rotaryevaporation to syrup, incubation with 2:1 mix of TFA and CH2Cl2 for 2 hours at 
RT, and rotaryevaporated to syrup. Five mL of ddH2O was added to the syrup and 
washed 3 times with ethyl ether until the organic layer turned colorless. In some cases 
when further purification was necessary, the dipeptide concentrate was acidified to pH ~2 
and applied to a Dowex 50W-X2 cation exchange column (Sigma) in the H+ form (1.6 
cm x 50 cm) and eluted with 1000 mL with a linear gradient of 0-0.5M HCl. The 
fractions were spotted on a TLC and visualized with ninhydrin spray (Sigma). The purity 
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of the dipeptide was determined by 1H NMR. 1H NMR (D2O) for D-Ala-L-Val: δ 0.75 
[6H, dd, J = 6.9 and 16, -CH(CH3)2], 1.35 (3H, d, J = 7.1, -CH3), 2.0 [1H, m, -
CH(CH3)2], 3.9 (1H, q, J = 7.2, 7.0 and 21.3, -CH(CH3)-], 3.93 {1H, d, J = 5.6, -
CH[CH(CH3)2]-} (Figure 2.10). 
 
Figure 2.10. 1H MR spectrum of D-Ala-L-Val at pD ~8.0. 
 
2.2.3.2. Synthesis of D-Ala-L-Ile 
The synthesis of D-Ala-L-Ile was carried out as described for D-Ala-L-Val. The purity of 
the dipeptide was determined by 1H NMR. 1H NMR (D2O) for D-Ala-L-Ile: δ 0.71 (3H, t, 
J = 7.4 and 14.9, -CH2CH3), 0.74 [3H, d, J = 6.9, -CH(CH3)CH2CH3], 1.00 and 1.23 (2H, 
m, -CH2CH3), 1.32 (3H, d, J = 7.1, -CH3), 1.72 [1H, m, -CH(CH3)CH2CH3], 3.88 [1H, q, 
J = 7, 7.1 and 21.2, -CH(CH3)-], 3.94 {1H, d, J = 5.9, -CH [CH(CH3)CH2CH3]-} (Figure 
2.11). 
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Figure 2.11. 1H MR spectrum of D-Ala-L-Ile at pD ~8.0. 
 
2.2.3.3. Synthesis of D-Ala-L-Met 
The synthesis of D-Ala-L-Met was carried out as described above. The purity of 
the dipeptide was determined by 1H NMR. 1H NMR (D2O) for D-Ala-L-Met: δ 1.32 (3H, 
d, J = 7.1, -CH3), 1.80 and 1.96 (2H, m, -CH2CH2SCH3), 1.94 (3H, s, -SCH3), 2.35 and 
2.43 (2H, m, -CH2CH2SCH3), 3.85 [1H, q, J = 7.1, 7.1 and 21.2, -CH(CH3)-], 4.14 [1H, 
q, J = 4.4, 5 and 13.8, -CH(CH2CH2SCH3)-] (Figure 2.12). 
 
Figure 2.12. 1H MR spectrum of D-Ala-L-Met at pD ~8.0. 
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2.2.3.4. Synthesis of L-Val-L-Glu 
The synthesis of L-Val-L-Glu was carried out as described above with the 
exception of the last purification step. The pH of the dipeptide was adjusted to ~12 with 
NH4OH and then applied to a Dowex AG1-X8 anion exchange column in the acetate 
form. The column was subsequently washed with ddH2O. The dipeptide substrate was 
typically eluted with a 1000 mL with a gradient of 0-1M acetic acid. The same 
purification procedure was used for all glutamate containing dipeptides. The purity of the 
dipeptide was determined by 1H NMR. 1H NMR (D2O) for L-Val-L-Glu: δ 0.79 [6H, dd, 
J = 6.9 and 18.5, -CH(CH3)2] ,  1.83 [3H, m, -CH(CH3)2, -CH2CH2CO2H], 2.08 [2H, t, J 
= 8.4 and 17, -CH2CH2CO2H] , 3.08 {1H, d, J = 6.1, -CH[CH(CH3)2]-}, 4.2 [1H, q, J = 
4.6, 4 and 13.4, -CH(CH2CH2CO2H)-] (Figure 2.13). 
 
Figure 2.13. 1H MR spectrum of L-Val-L-Glu at pD ~8.0. 
 
2.2.3.5. Synthesis of D-Ala-D-Glu 
The synthesis of D-Ala-D-Glu was carried out as described for L-Val-L-Glu. The 
purity of the dipeptide was determined by 1H NMR. 1H NMR (D2O) for D-Ala-D-Glu: δ 
1.38 (3H, d, J = 7.1, -CH3), 1.76 and 1.95 (2H, m, -CH2CH2CO2H), 2.09 (2H, t, J = 8.4 
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and 16.5, -CH2CH2CO2H), 3.92 [1H, q, J = 7.1, 7.1 and 21.3, -CH(CH3)-], 4.0 [1H, q, J = 
4.3, 5.1 and 13.7, -CH(CH2CH2CO2H)-] (Figure 2.14). 
 
 
Figure 2.14. 1H MR spectrum of D-Ala-D-Glu at pD ~8.0. 
 
2.2.3.6. Synthesis of D-Val-D-Glu 
The synthesis of D-Val-D-Glu was carried out as described for L-Val-L-Glu. The 
purity of the dipeptide was determined by 1H NMR. 1H NMR (D2O) for D-Val-D-Glu: δ 
0.85 [6H, dd, J = 2.8 and 6.8, -CH(CH3)2] ,  1.76 and 1.94 [3H, m, -CH(CH3)2, -
CH2CH2CO2H], 2.10 [2H, t, J = 7.7 and 16.4, -CH2CH2CO2H] , 3.4 {1H, d, J = 6.6, -
CH[CH(CH3)2]-}, 3.99 [1H, q, J = 4.3, 5.1 and 13.7, -CH(CH2CH2CO2H)-] (Figure 2.15). 
Figure 2.15. 1H MR spectrum of D-Val-D-Glu at pD ~8.0. 
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2.2.3.7. Synthesis of L-Ala-D-Glu 
The synthesis of L-Ala-D-Glu was carried out as described for L-Val-L-Glu. The 
purity of the dipeptide was determined by 1H NMR. 1H NMR (D2O) for D-Ala-L-Glu: δ 
1.33 (3H, d, J = 7, -CH3), 1.72 and 1.92 (2H, m, -CH2CH2CO2H), 2.06 (2H, t, J = 8.1 and 
16.1, -CH2CH2CO2H), 3.84 [1H, q, J = 7.1, 7.1 and 21.3, -CH(CH3)-], 3.96 [1H, q, J = 
4.2, 5.1 and 13.7, -CH(CH2CH2CO2H)-] (Figure 2.16). 
 
Figure 2.16. 1H MR of L-Ala-D-Glu at pD ~8.0. 
 
2.2.3.8. Synthesis of L-Val-D-Glu 
The synthesis of L-Val-D-Glu was carried out as described for L-Val-L-Glu. The 
purity of the dipeptide was determined by 1H NMR. 1H NMR (D2O) for D-Val-D-Glu: δ 
0.85 [6H, dd, J = 2 and 6.8, -CH(CH3)2] ,  1.74 and 1.94 [3H, m, -CH(CH3)2, -
CH2CH2CO2H], 2.08 [2H, t, J = 8 and 17.1, -CH2CH2CO2H] , 3.47 {1H, d, J = 6.6, -
CH[CH(CH3)2]-}, 3.98 [1H, q, J = 4.3, 5.1 and 13.7, -CH(CH2CH2CO2H)-] (Figure 2.17). 
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Figure 2.17. 1H MR spectrum of L-Val-D-Glu at pD ~7.0. 
 
2.2.3.9. Synthesis of D-Ala-L-Leu 
Synthesis of D-Ala-L-Leu was carried out as described earlier. The purity of the 
dipeptide was determined by 1H NMR. 1H NMR (D2O) for D-Ala-L-Leu: δ 0.75 [6H, dd, 
J = 6.3 and 20.2, -CH(CH3)2], 1.29 (3H, d, J = 7.1, -CH3), 1.46 [3H, m, -CH2CH(CH3)2], 
3.78 [1H, q, J = 7.1, 7.1 and 21.2, -CH(CH3)-], 4.03 {1H, t, J = 5.7, 8.7 and 14.5, -
CH[CH2CH(CH3)2]-} (Figure 2.18). 
 
Figure 2.18. 1H MR spectrum of D-Ala-L-Leu at pD ~7.0. 
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2.2.4. Solid phase synthesis of dipeptide libraries 
2.2.4.1.  Synthesis of L-X-L-Ala library 
The dipeptide libraries were typically synthesized as described by Song et al. 
[13]. Fmoc-Ala-Boc-Wang resin was weighed out in equal amounts into (19 x 0.014 
mmoles) separate eppendorf tubes and swollen overnight in an excess amount of dry 
N,N-dimethylformamide (DMF). The N-terminal Fmoc protecting group was removed 
from the Fmoc-Ala-Boc-Wang resin by incubating the resin with 20% piperidine in 
DMF. The deprotected Ala-Boc-Wang resin was subsequently washed 5 times with dry 
DMF. Three molar equivalents of N-terminally Fmoc-protected amino acids (in DMF) 
were added to the respective eppendorf tubes. Cysteine was excluded from the library due 
to potential unwanted side reactions. For the coupling reaction, 3 molar equivalents of 1-
hydroxybenzotriazole (HOBt) and 1,3-diisopropylcarbodiimide (DIC) were added. The 
eppendorf tubes containing the reaction mixtures were placed on a shaker for overnight 
incubation to be shaken gently at room temperature. In some instances the coupling step 
was repeated with a fresh batch of Fmoc-protected amino acids and coupling reagents. 
The 19 tubes were then emptied into a 10 mL syringe reactor. The combined resins were 
washed with CH2Cl2 and then with DMF. The N-terminal Fmoc-protecting group was 
subsequently removed by incubating the combined resins twice with 20% piperidine in 
DMF, in 15 intervals. The resin was then sequentially washed with DMF, CH2CL2, and 
MeOH. The resin was dried with dry nitrogen for 30 minutes, and the deprotected 
dipeptide was cleaved from the resin. The cleavage cocktail consisted of v/v 90% 
trifluoroacetic acid, 5% thioanisole, 3% 1,2-ethanedithiol, and 2% anisole. One-half of 
the cocktail was added to the resin and stirred occasionally for 2 hours. The brown liquid 
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was eluted into a 100 mL roundbottom flask. The procedure was repeated. After the final 
elution, the resin was washed 3 times with trifluoroacetic acid and eluted into the same 
flask. The dark brown liquid was then rotaryevaporated to a thick syrup. A minimal 
amount of water was added to the syrup. The cloudy liquid was washed with ethyl ether. 
The organic layer was discarded, and the pale yellow liquid was washed with ethyl ether 
until the organic layer was colorless. The water phase containing the dipeptide was then 
lyophilized. Unless stated otherwise, the same general procedure for synthesis was 
followed for the remaining dipeptide libraries described in the later sections of this 
chapter. The purity of libraries was confirmed via ESI-MS. For mass spectrometry, the 
library was diluted with a solution containing a 50:50 mixture of water and acetonitrile 
and 0.2% (v/v) formic acid (Figure 2.19). 
 
 
Figure 2.19. ESI-MS of L-X-L-Ala library: All but L-Gly-L-Ala, L-Asp-L-Ala, L-
Glu-L-Ala and L-Cys-L-Ala were present. The spectra was acquired in ES+ mode. 
For the L-X-L-Ala library, two major side products with M+1 values of 187.2 and 
192.2 were detected. 
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2.2.4.2. Synthesis of L-X-L-Leu library 
The synthesis of the L-X-L-Leu library was carried out as described for the L-X-
L-Ala library. The purity of the library was determined by ESI-MS in ES+ mode (Figure 
2.20). 
 
Figure 2.20. ESI-MS of L-X-L-Leu library: the library was missing Gly-Leu, Ser-
Leu, Cys-Leu, Asp-Leu, Glu-Leu and Trp-Leu. Major side products were with the 
M+1 values of 192.2, 208.2, 222.2 and 244.2.  
 
2.2.4.3. Synthesis of L-X-L-Ile library 
 The synthesis of the L-X-L-Ile library was carried out as described for L-X-L-Ala 
library. The purity of the library was determined by ESI-MS in ES+ mode (Figure 2.21). 
 
Figure 2.21. ESI-MS of L-X-L-Ile library: The library was missing L-Cys-L-Ile. 
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2.2.4.4. Synthesis of L-X-L-Phe library 
 The synthesis of the L-X-L-Phe library was carried out as described for L-X-L-
Ala library. The purity of the library was determined by ESI-MS in ES+ mode (Figure 
2.22). 
 
Figure 2.22. ESI-MS of L-X-L-Phe library: The library was missing L-Cys-L-Ile. 
 
2.2.4.5. Synthesis of D-Ala-L-Xxx library 
 Nineteen Fmoc-Xxx-Boc-Wang resins were weighed out in equal amounts (0.014 
mmoles) into separate eppendorf tubes and swollen overnight in an excess amount of dry 
DMF. The N-terminal Fmoc protecting group was removed from the 19 resins as 
described earlier. The deprotected resins were subsequently washed 5 times with dry 
DMF. Three molar equivalents of N-terminally Fmoc-protected D-alanine (in DMF) were 
added to the respective eppendorf tubes. The procedure from here on was as described for 
L-X-L-Ala dipeptide library. The purity of the dipeptide library was determined by ESI-
MS in ES+ mode. Two mass spectrums of the same sample are provided for the D-Ala-L-
Xxx library due to an apparent change in ionization properties of the sample from the 
start of sample injection to the finish of sample injection (Figure 2.23). 
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Figure 2.23. ESI-MS of D-Ala-L-X library: The library was missing Gly-L-Ala, D-
Pro-L-Ala, D-Thr-L-Ala and D-Cys-L-Ala. Major side product was with the M+1 
value of 192.5. ote the difference in the intensities of D-Ala-L-Ala, D-Ala-L-Phe 
and of D-Ala-L-Trp peaks between the two mass spectrums. 
 
2.2.4.6. Synthesis of D-X-L-Glu library 
 Synthesis of the D-X-L-Glu library was carried out as described for L-X-L-Ala 
library. The purity of the library was determined by ESI-MS in ES+ mode (Figure 2.24). 
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Figure 2.24. ESI-MS of D-X-Glu library: The library was missing Gly-L-Glu and D-
Cys-L-Glu. 
 
2.2.5. ESI-MS assay for dipeptide epimerase activity 
Incubation of a putative dipeptide epimerase and a dipeptide library was carried 
out in D2O buffer with the following conditions: 20 mM NH4HCO3, pH 8.0, and 100 µM 
of dipeptide mixture in a 250 µL volume. Fifty µL of the mixture was set aside as a 
negative control. One µM of putative dipeptide epimerase was used for the assay. The 
mixture was incubated for 16 hours at 30º C. Both mixtures were quenched with 
concentrated ammonium hydroxide due to its volatile nature before being flash-frozen in 
liquid nitrogen and lyophilized. The residue was taken up in the same volume of water 
and analyzed by ESI-MS in ES+ mode. 
 
2.2.6. Polarimetry assay for dipeptide epimerase activity 
2.2.6.1. Determination of molar ellipticity for dipeptide substrates 
The difference in the starting optical rotation and the optical rotation of the 
epimerized dipeptide at equilibrium at a given concentration was used as the value for 
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molar ellipticity. The Hg 405 nm filter was used for all substrates. The molar ellipticities 
are listed in Table 2.2. 
 
2.2.6.2. Polarimetry assay for kinetic constant determination 
Kinetic parameters for dipeptide epimerases were determined via polarimetry. 
The assays were carried out in a 100 mm pathlength cuvette at room temperature. Typical 
buffer conditions for the assay were the following: 20 mM Tris-HCl, pH 8.0, and 10 mM 
MgCl2. The choice of substrates for the determination of kinetic parameters was 
determined based on results from the ESI-MS assay. For a typical assay, a final 
concentration of 20-100 nM of dipeptide epimerase was used. All assays were performed 
at 405 nm wavelength. 
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Compound Degrees/mM (at ~25 °C) 
D-Ala-D-Ala 0.01902 
D-Ala-L-Ala 0.01633 
D-Ala-L-Ile 0.0050 
D-Ala-L-Leu 0.01448 
D-Ala-L-Met 0.00201 
D-Ala-L-Val 0.00621 
L-Ala-D-Ala 0.01527 
L-Ala-D-Glu 0.00320 
L-Ala-L-Ala 0.01814 
L-Ala-L-Glu 0.00270 
L-Ala-L-Leu 0.02046 
L-Ala-L-Met 0.00221 
L-Ile-L-Glu 0.00472 
L-Leu-L-Ala 0.01886 
L-Leu-L-Glu 0.00435 
L-Phe-L-Ala 0.03787 
L-Pro-L-Glu 0.00424 
L-Tyr-L-Ala 0.04791 
L-Val-D-Glu 0.00876 
L-Val-L-Glu 0.00517 
L-Val-L-Ala 0.02638 
 
Table 2.2. List of experimentally determined molar ellipticities for the dipeptides 
substrates of BT1313 and CHU2140. 
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2.3. Genomic context and preliminary predictions 
The pair-wise sequence identity between the various uncharacterized members in 
the dipeptide epimerase family to the previously characterized homologues are usually 
>30%. As described earlier, a few sequence motifs help identify the enolase superfamily 
members and place them into subgroups and families. For the dipeptide epimerases, the 
family determinant is the DxD motif at the end of the eighth β-strand. The 20s and 50s 
loop sequences, however, give clues about the possible substrate specificity. In addition 
to other putative dipeptide epimerases, structure-based homology models of CHU2140 
and BT1313 were constructed in Prof. Matthew Jacobson’s lab at UCSF. The two 
enzymes were chosen primarily due to low sequence identity to previously characterized 
dipeptide epimerases and for the high potential of discovering dipeptide epimerases of 
novel substrate specificities. BT1313 was chosen also because of the potential for a new 
structural basis for the recognition of L-Ala-D/L-Glu substrate. The homology models 
were subsequently subjected to virtual library screening by flexible docking with all 
possible dipeptide substrates [14]. 
 
2.3.1. Analysis of multiple sequence alignment 
BT1313 shares 31% and 36% sequence identity, respectively, with the previously 
characterized AEEs from E. coli and B. subtilis. CHU2140 shares 39% and 28% 
sequence identity with the known AEEs. Although the sequence identity is low, the 
conserved sequence motifs enable placement of these enzymes into the dipeptide 
epimerase family. As evidenced by multiple sequence alignment, however, the predicted 
capping loop sequences for both BT1313 and CHU2140 are divergent (Figure 2.25).  
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The presence of an Arg residue in the predicted 20s loops of BT1313 and BF276 
is one of the characteristics similar to the known AEEs. The Arg residue plays an 
important role in the recognition of the Glu moiety of the L-Ala-D/L-Glu substrate. Thus, 
although the overall sequence identity to the previously characterized AEE’s is low, 
perhaps the presence of this positively charged residue can spare for an anionic residue in 
the C-terminal side of the dipeptide substrate. However, the 20s loop sequence for 
CHU2140 lacks a positively charged residue in the expected position required for the 
specificity of a partially anionic substrate. Instead, the sequence contains multiple 
hydrophobic residues, suggesting a different dipeptide substrate (Figure 2.25). 
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2.3.2. Genomic context 
The operon contexts for the three putative dipeptide epimerases are somewhat 
limited (Figure 2.26). The dipeptide epimerase from Cytophaga hutchinsonii seems to 
lack operon context. The nearest neighboring genes are 281 and 322 base pairs away 
from the start and stop codons of CHU2140, respectively. The genomic context for the 
homologous Bacteroides sp. dipeptide epimerases proved to be much more useful. For 
BT1313, the operon contains one additional gene with the locus tag BT1314 and encodes 
for a putative dipeptidyl-dipeptidase. This is well in accord with the hypothesis that 
BT1313 utilizes a dipeptide substrate. The BF2763 operon, however, is somewhat 
different and contains two additional genes. Downstream of BF2763 in the operon is a 
gene (BF2762) that is orthologous to transglutaminases which are known to catalyze 
transamination reactions. In the opposite direction, however, is a gene annotated as a 
putative peptidase (BF2764), which is orthologous to the dipeptidyl-dipeptidase in the 
BT1313 operon. 
 
 
 
 
  
 
Figure 2.26. Genomic context of BF2763, BT1313 and CHU2140 dipeptide 
epimerases. Orthologous genes are color-coded in the same fashion. 
BF2762 BF2763 BF2764 
BT1314 BF1313 
CHU2140 CHU2141 CHU2139 
∆332            ∆281 
∆18 
∆31  ∆148 
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2.3.3. Computational predictions 
The computational predictions relating to the substrate specificity of the enzymes 
were carried out in Prof. Matthew Jacobsons lab at UCSF. First, structure-based 
homology models were constructed which will be discussed in later parts of this chapter. 
Based on the homology models, flexible docking was carried out and lists of putative 
dipeptide substrates were provided [14]. This was done for a number of previously 
uncharacterized AEE family members. It was observed that the list of substrates for any 
individual enzyme could differ dramatically from the prediction of the general substrate 
specificity for a group of orthologous enzymes. Several groups of enzymes with 
divergent substrate specificities were determined. BT1313 and BF2763 were thus 
clustered together with enzymes that can facilitate the epimerization of Xxx-Glu 
dipeptides; CHU2140 was clustered together with enzymes that catalyze the 
epimerization of Ala-hydrophobic dipeptides (Figure 2.27). 
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Figure 2.27. Clustering of the AEE family members into discrete subfamilies based 
on their predicted substrate specificities and relatedness in sequence. CHU2140 was 
predicted to catalyze the epimerization of Ala-hydrophobic dipeptides and 
BT1313/BF2763 of Xxx-Glu dipeptides. 
 
As described in later portions of this chapter the substrate specificity was predicted 
somewhat accurately only for CHU2140. Details about the results for flexible docking 
can be found in Table 3. It is evident that the technology for predicting substrate 
specificity is still the developmental stage since the list of putative substrates for BT1313 
and BF2763 do not contain any true substrates of the enzyme. The more general 
prediction, however, which is based on the docking results of many orthologous 
enzymes, accurately groups BT1313 and BF2763 together with enzymes that catalyze the 
epimerization of Xxx-Glu dipeptides. 
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Rank CHU2140 Rank BT1313 Rank BF2763 
 N-term C-term  N-term C-term  N-term C-term 
1 D-Ala Gln 1 Thr Thr 1 Ser Gln 
2 D-Ala Val 2 Thr Asn 2 Thr Phe 
3 D-Ala Asn 3 Ser Tyr 3 Thr Val 
4 D-Ala Leu 4 Thr Leu 4 Thr Ser 
5 D-Ala Ile 5 Ser Val 5 Ser Asn 
6 D-Ala Ser 6 Ser Asn 6 Ser Val 
7 D-Ala Ala 7 Ser Ile 7 Ser Phe 
8 D-Ala Trp 8 Thr Met 8 Ser Ile 
9 D-Ala Phe 9 Ser Met 9 Cys His 
10 D-Ala Thr 10 Ser His 10 Thr Thr 
11 D-Ala Cys 11 Thr Cys 11 Pro Ile 
12 D-Ala Gly 12 Ser Leu 12 Thr Met 
13 D-Ala Met 13 Ser Gln 13 Thr Cys 
14 D-Ala His 14 Ser Ser 14 Ser Thr 
15 D-Ala Arg 15 Cys Val 15 Ser His 
16 D-Ala Pro 16 Ser Thr 16 Ser Leu 
17 Ser Val 17 Ser Phe 17 Asn Phe 
18 Thr Asn 18 Thr Trp 18 Cys Ile 
19 Thr Val 19 Thr Lys 19 Ser Ser 
20 Thr Thr 20 Pro Asn 20 Ser Met 
30 D-Ala Glu 50 Gln Glu 50 Val Val 
 
Table 2.3. The list of predicted substrates for BF2763, BT1313 and CHU2140. The 
first 20 high-ranking substrates for CHU2140 contain several true substrates, while 
there were no true substrates in the first 200 highest ranking dipeptides for BF2763 
and BT1313. 
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2.3.4. Phylogenetic profiling 
Phylogenetic profiling of the MLE subgroup members with divergent sequences 
was carried out in Prof. Patricia Babbitt’s lab at UCSF. Although the usual rooted 
dendrogram style depiction for enzyme relatedness is useful, a novel and a more 
advanced tool has recently been adapted by the Babbitt lab. The method utilizes the 
NCBI blastp expectation value to cluster related enzymes together. Any two or more 
related proteins are thus connected if they are within a certain threshold expectation 
value. As the expectation value is decreased, groups of distantly related sequences bud 
off to clusters of even more closely related enzymes. Such a method is useful in 
identifying groups of isofunctional enzymes and gives clues to new classes of enzymes. 
The method is even more potent in trying to elucidate the function of unknown members 
in the enolase superfamily that share very little sequence identity to other already 
characterized members. The sequence relationship diagram depicted below describes the 
relationships between the different members in the MLE subgroup (Figure 2.28).  
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B. subtilis
AEE
C. hutchinsonii
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AFE
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Figure 2.28. Sequence relatedness diagram of the MLE subgroup members 
containing divergently related dipeptide epimerases. 
 
2.4. Identification of dipeptide epimerase activity 
2.4.1. Dipeptide library screening via mass-spectrometry 
The general procedure that was discussed earlier was used for library screening. 
Initially, L-Ala-L-Xxx and Gly-L-Xxx libraries were screened. Additional libraries were 
synthesized as needed. For example, if from the L-Ala-L-Xxx library, L-Ala-L-Leu was 
epimerized, the L-Xxx-L-Leu library was synthesized to discover other potential 
substrates. In addition to 16 hours, shorter incubation times were utilized to identify the 
better substrates for kinetic analysis.  
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 2.4.1.1. Screening results for BF2763 
The enzyme was screened against the Gly-L-Xxx and L-Ala-L-Xxx libraries. Due 
to the amount of impurities in the protein sample any further analysis was halted. The two 
libraries, however, gave the expected overall result that was predicted for both BF2763 
and BT1313. For both libraries, only Gly-L-Glu and L-Ala-L-Glu were epimerized, 
indicating specificity for the C-terminal Glu moiety of the substrate.  
 
2.4.1.2. Screening results for BT1313 
The enzyme was screened as described earlier. Gly-L-Xxx and L-Ala-L-Xxx 
libraries gave identical results to that for BF2763. In addition to these two libraries, the 
L-Xxx-L-Glu library was screened as well. As expected, more than just Gly-L-Glu and 
L-Ala-L-Glu were epimerized in an overnight incubation (Figure 2.29). Because of the 
biological relevance of D-amino acids in the bacteria, D-Xxx-L-Glu library was 
synthesized and was subjected to the mass-assay with BT1313. The composite results for 
library screening can be found in Table 2.4.  
 L-Ala-L-X Gly-L-X L-X-L-Glu L-X-L-Glu D-X-L-Glu 
X 16h 16h 16h 0.5h 2h 
Ala – – xxxx xxxx xxxx 
Ser – – xxxx – – 
Pro – – xxxx xxx – 
Val – – xxxx xxx xx 
Thr – – xxxx – – 
 
Table 2.4. ESI-MS assay screening results for BT1313. The letter “x” denotes 
epimerization: x < 50%, xx ~ 50%, xxx > 50%, xxxx > 90%; “–“ denotes no 
conversion and “?” denotes ambiguity (i.e. it was unclear whether there was any 
epimerization or not).  
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Ile – – xxxx x – 
Leu – – xxxx x – 
Asn – – ? – – 
Asp – – – – – 
Gln – – xx – – 
Lys – – xx – – 
Glu xxxx xxxx – – – 
Met – – xxxx – – 
His – – xx – – 
Phe – – xxxx – – 
Arg – – – – – 
Tyr – – xx – – 
Trp – – xxx – – 
 
Table 2.4 (cont). 
 
 
 Figure 2.29. ESI-MS assay results for BT1313 with L-X-L-Glu library. Fully 
epimerized substrates are denoted with a ++++. 
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2.4.1.3. Screening results for CHU2140. 
The enzyme was screened as described earlier. Initial screening was done with 
Gly-L-Xxx and L-Ala-L-Xxx libraries (Figure 2.30). Due to a number of hits from the L-
Ala-L-Xxx library, additional libraries were synthesized and subjected to similar 
screening conditions. The results from the mass assay are indicative of the preference of a 
small hydrophobic amino acid in the N-terminal position and a small hydrophobic amino 
acid in the C-terminal position of the substrate. These results correlated well with the 
overall prediction of an Ala-hydrophobic dipeptide substrate. The full list of screened 
substrates and observed hits can be found in Table 2.5. 
 
Figure 2.30. ESI-MS assay results for CHU2140 with L-Ala-L-X library. Fully 
epimerized substrates are denoted with a ++++. 
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Gly-L-X L-Ala-L-X L-X-L-Ala L-X-
L-Ile 
L-X- 
L-Leu 
L-X-L-Phe D-Ala-
L-X 
X 16h 4h 16h 4h 4h 1h 4h 4h 4h 1h 4h 
Ala xxx – xxx xxx xxx xxx xx – xxx xx xxx 
Ser ? ? xxx xxx – – – – – – NA 
Pro – – – – xxx xx – – – – NA 
Val xxx x xxx xxx xxx xx – – – – NA 
Thr xx – xxx xx ? – – – – – NA 
Ile xxx x xxx xx xxx xx – – xx x xx 
Leu xxx x xxx xx xxx xx – – xx x xx 
Asn – – – – – – – – – – – 
Asp – – – – NA NA – – – – – 
Gln – – – – – – – – – – – 
Lys – – – – – – – – – – – 
Glu – – – – NA NA – – – – – 
Met xxx – xxx xxx xx xx – – xx x xxx 
His – – – – – – – – – – – 
Phe xxx x xxx xx xxx xx – – xxx xx xx 
Arg – – – – – – – – – – – 
Tyr – – xx – xxx – – – – – – 
Trp x – x – x x – – ? ? – 
 
Table 2.5. ESI-MS assay screening results for CHU2140. The letter “x” denotes 
epimerization: x < 50%, xx ~ 50%, xxx > 50; “–“ denotes no conversion, “?” denotes 
ambiguity (i.e. it was unclear whether there was any epimerization or not) and 
“A” denotes the dipeptides that were not applicable for that library.  
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2.4.2 Dipeptide epimerase kinetics via polarimetry 
 The kinetic constants for both newly discovered dipeptides epimerases were 
determined via polarimetry. Substrates for kinetic analysis were chosen based on the 
results from the ESI-MS assay. The substrates that were commercially unavailable were 
synthesized where it was deemed necessary. 
 
2.4.2.1. Results for BT1313 
 BT1313 was assayed with a number of dipeptides that contained glutamate in the 
C-terminal position. Although it was expected from the results of the ESI-MS assay that 
the number of potential substrates would be large, only a few kinetically competent 
substrates were detected. To validate for a potential cross contamination of the E. coli 
AEE in the enzyme preparation, the polarimetry assay was also carried out with L-Ala-L-
Asp. The second order rate constants for L-Ala-L-Asp and L-Ala-L-Glu as catalyzed by 
E. coli AEE are almost equal. However, no L-Ala-L-Asp epimerase activity was detected 
for BT1313. The best substrate for the enzyme was determined to be L-Ala-L-Glu with a 
kcat of 104 s
-1, KM of 1.8 mM, and a kcat/KM of 5.8 x 10
4 M-1s-1. The complete list of 
kinetic parameters for BT1313 can be found in Table 2.6. The kinetic constants indicate a 
preference for L-Glu in the C-terminal position of the dipeptide substrate. This 
stereochemical preference is evidenced in an elevated value of kcat and a lowered value of 
KM for both L-Ala-L-Glu and L-Val-L-Glu. The last column in the table contains the 
rates of exchange of the α-proton. The exchange rates and the possible meaning of the 
values will be discussed in a later section.  
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Substrate KM (M) kcat (s
-1) kcat/KM (M
-1s-1) kexc (s
-1) 
L-Ala-D-Glu 4.2 x 10-3 38 9.1 x 103 38 
L-Ala-L-Glu 1.8 x 10-3 104 5.8 x 104 - 
L-Val-D-Glu 5.1 x 10-3 32 6.3 x 103 38 
L-Val-L-Glu 1.8 x 10-3 76 4.2 x 104 - 
L-Ile-L-Glu 5.9 x 10-3 30 5.1 x 103 - 
L-Leu-L-Glu - - 3.9 x 103 - 
L-Pro-L-Glu - - 1 x 102 - 
D-Ala-D-Glu - 0.3 - 1.3 
D-Val-D-Glu - 0.04 - 1.8 
 
Table 2.6. Kinetic constants as determined via polarimetry and MR for BT1313. 
 
2.4.2.2. Results for CHU2140 
 The initial kinetic constants for CHU2140 were determined with dipeptides that 
contain L-Ala in the N-terminal position. The results, however, suggested an alternate 
substrate. AEE is known to play a part in the pathway that recycles the L-Ala-D-Glu 
portion of the murein peptide, an important bacterial cell wall component. It was thus 
hypothesized that CHU2140 instead could utilize the D-Ala-D-Ala fragment of the same 
peptide molecule. The kinetics were determined for a number of D-Ala containing 
dipeptides, and the best substrate was determined to be D-Ala-L-Ala with a kcat of 58 s
-1, 
KM of 1.1 mM and a kcat/KM of 5.5 x 10
4 M-1s-1. The full list of results can be found in 
Table 2.7. Additionally, the enzyme was subjected to the epimerization assay with L-Ala-
D-Glu substrate but no epimerization was detected. 
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Substrate KM (M) kcat (s
-1) kcat/KM (M
-1s-1) 
L-Ala-L-Ala 5 x 10-3 37.5 7.5 x 103 
L-Ala-L-Val 1 x 10-2 7.5 7.5 x 102 
L-Ala-L-Met 2.5 x 10-3 15 6 x 103 
L-Ala-L-Leu 1.4 x 10-3 1.4 1 x 103 
L-Val-L-Ala 9.9 x 10-3 5.5 5.5 x 102 
L-Phe-L-Ala 3.4 x 10-3 7.5 2.2 x 103 
L-Leu-L-Ala 2.2 x 10-2 21.5 9.6 x 102 
L-Tyr-L-Ala 3.6 x 10-3 3 8.5 x 102 
D-Ala-D-Ala 1.9 x 10-3 43 2.3 x 104 
D-Ala-L-Ala 1.1 x 10-3 58.4 5.5 x 104 
D-Ala-L-Val 5 x 10-4 18.5 3.7 x 104 
D-Ala-L-Met 1.7 x 10-3 12.5 7.5 x 103 
D-Ala-L-Leu 1.1 x 10-3 5 4.5 x 103 
D-Ala-L-Ser 6.2 x 10-3 68.6 1.1 x 104 
 
Table 2.7. Kinetic constants as determined via polarimetry for CHU2140. 
 
2.4.3. α-Proton exchange kinetics via NMR 
 It is well established that members of the enolase superfamily can exchange the 
proton alpha to the carboxylate group [29]. This is possible due to the polyprotic nature 
of the acid-base catalysts (by means of rotation about the Cδ–Nψ sigma bond of lysine). If 
the putative substrate molecule is not correctly oriented in the active site, the general base 
will also act as the general acid and the substrate- or solvent-derived proton or deuterium, 
respectively, can be introduced into the product molecule from the face of abstraction. 
This results in no change in the stereochemistry but of incorporation of a deuterium atom 
into the product molecule if the reaction is carried out in D2O buffer. Several substrates 
that seemingly underwent epimerization in the ESI-MS assay demonstrated poor 
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epimerization kinetics when assayed via polarimetry. The latter is true in particular for 
BT1313. 
 
2.4.3.1. Results for BT1313 
 The exchange rates were determined for two substrates that exhibited good kinetic 
constants (L-Ala-D-Glu and L-Val-D-Glu) and for two substrates that underwent 
apparent epimerization in the ESI-MS assay but exhibited poor epimerization kinetics (D-
Ala-D-Glu and D-Val-D-Glu). For L-Ala-D-Glu and L-Val-D-Glu the rates of 
epimerization and exchange were the same, which can be explained by epimerization 
occurring in D2O buffer (i.e. the acid-base catalysts were fully equilibrated with solvent 
deuterium). In case of the poor D-alanyl and D-valinyl substrates, however, the rate of 
exchange was much larger than the apparent kcat value for epimerization. This might 
suggest improper binding of the substrate molecule, where the α-proton is close enough 
to the base for proton abstraction, but too far away from the catalytic acid for the 
epimerization to occur. The detailed results can be found in Table 2.6. 
 
2.4.4. Discussion 
 Two novel dipeptide epimerases were identified from Bacteroides 
thetaiotaomicron and Cytophaga hutchinsonii. The proteins were cloned into pET-17b 
expression vectors, overexpressed, and purified to homogeneity. The two enzymes were 
subjected to dipeptide library screening via mass-spectrometry and substrate candidates 
were chosen for kinetic analysis. 
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2.4.4.1. BT1313 dipeptide epimerase function 
 New protein sequences in the enolase superfamily are identifiable with relative 
ease. The three major subgroups – enolase, mandelate racemase, and muconate 
lactonizing enzyme – all have common features that make it relatively easy to assign the 
subgroup as well. The difficulty is identification of the substrate specificity. BT1313 was 
categorized as an MLE subgroup member, and was placed in the subclass of dipeptide 
epimerases due to the presence of a DxD motif at the end of the 8th β-strand. The more 
precise prediction for substrate specificity was provided by Prof. Matthew Jacobson’s lab 
at UCSF, with the enzyme predicted to catalyze epimerization of Xxx-Glu dipeptides. 
Additional preliminary clues to the dipeptide epimerase function of BT1313 came from 
the genomic context, where the gene is an operon with a dipeptidyl dipeptidase 
homologue. The predictions were verified experimentally. BT1313 was determined to be 
the founding member of the third AEE with kinetic parameters comparable to those of the 
previously characterized AEEs.  
 
2.4.4.2. CHU2140 dipeptide epimerase function 
 Initial predictions placed CHU2140 into the MLE subgroup and into the dipeptide 
epimerase class. However, the lack of a positively charged residue in the 20s loop 
sequence suggested a different substrate specificity when compared to BT1313. The 
computational predictions suggested that CHU2140 would catalyze the epimerization of 
Ala-hydrophobic dipeptides. The predictions were confirmed experimentally as was 
described for BT1313. A number of substrates were chosen for kinetic analysis based on 
the results from the ESI-MS assay. The best substrate turned out to be of D-Ala-L-Ala. 
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There is no easy way to say whether the epimerization of D-Ala-D/L-Ala substrate is the 
true function of CHU2140. However, the kinetic parameters for other previously 
characterized dipeptide epimerases are in good agreement with the kinetic constants 
determined for CHU2140. 
 
2.5. Crystal structures and homology models 
 The proteins were expressed without an affinity tag and purified to homogeneity. 
All crystallographic studies were carried out at Prof. Steven Almo’s lab at Albert Einstein 
College of Medicine in New York. Homology modeling for all enzymes was carried out 
in Prof. Matthew Jacobson’s lab at UCSF. 
 The goal of this work is to better understand the structure-function relationships 
of the members in the enolase superfamily and to perfect the methodology of functional 
assignment based on sequence information alone. Homology models were utilized for in 
silico library screening to give insights into the identities of the active site residues and 
also for the possible interaction sites between the enzyme and the substrate molecule. 
Crystal structures are a useful tool for two major reasons. Firstly, if the function and the 
substrate specificity of an enzyme are unknown, the crystal structure can be utilized as 
the scaffold for virtual substrate library screening. This is especially useful for enzymes 
that lack operon context or are too divergent for homology modeling. Secondly, the 
crystal structure confirms the computational predictions for structure and substrate 
interactions with the enzyme. The latter is useful in perfecting the methodology for 
structure prediction. 
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2.5.1. Bacteroides thetaiotaomicron dipeptide epimerase 
2.5.1.1. Predicted tertiary structure for the enzyme 
 BT1313 was homology modeled based on the Bacillus subtilis AEE structural 
scaffold. The enzyme was predicted to have the common bidomain structure with an N-
terminal “capping” domain and the C-terminal (β/α)7β barrel domain (Figure 2.31).  
 
Figure 2.31. Predicted tertiary structure of the BT1313 dipeptide epimerase. The 
pose contains L-Ala-L-Glu in the active site. Color coding: pink – substrate 
specificity, green – catalysis, blue – metal binding. 
 
Importantly, the homology model predicts the positions of the active site residues that 
form the key interactions with the substrate molecule. In the B. subtilis AEE structure, 
Arg24 interacts with the γ-carboxylate group of the Glu side chain of the substrate 
molecule. In the BT1313 homology model, an Arg residue is present at a neighboring 
position. This Arg residue is therefore predicted to contribute to substrate recognition in a 
similar fashion. The numbering of the residues is based on the protein sequence deposited 
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in the NCBI database. The residues that are important for catalysis and for substrate 
binding were predicted to be as follows: Arg 68 interacts with the γ-carboxylate group of 
the Glu moiety of the substrate molecule; Lys 200 and Lys 298 act as the acid-base 
catalysts; Asp 224, Glu 251 and Asp 276 act as the metal binding ligands, and Asp 348 
and Asp 350 provide the necessary interactions for the recognition of the α-ammonium 
group of the dipeptide substrate (Figure 2.32). 
 
Figure 2.32. The active site of BT1313 as predicted by homology modeling. The 
numbering is based on the full-length protein sequence from the CBI non-
redundant database. 
 
2.5.1.2. Analysis of BT1313 crystal structure 
 BT1313 was crystallized by Prof. Steven Almo’s lab at AECOM. Multiple 
liganded structures were solved from 1.6 to 2Å resolution. Attempts were made to solve 
the unliganded structure but in all attempts the barrel portion of the enzyme was 
disordered. The crystal structure with L-Ala-D-Glu bound in the active site will be 
Lys200 Lys298 
Arg68 
Asp350 
Asp348 
Asp276 
Glu251 
Asp224 
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discussed as the L-Ala-D-Glu substrate had the best coordination geometry with respect 
to the bound magnesium ion. The asymmetric unit contained two polypeptides and 
conformed to the classical modified TIM-barrel fold (Figure 2.33). Importantly, all loops 
are ordered in the structures. 
 
Figure 2.33. Polypeptide B from the BT1313 liganded structure solved at 2Å 
resolution. Important active site residues are highlighted. 
 
In several of the solved structures, the α-carboxylate group of the substrate molecule had 
no direct coordination to the divalent metal ion, but rather through active site water 
molecules (Figure 2.34). Due to the substrate’s positioning in the wrong coordination 
sphere, the acid-base catalysts were much too far away to resemble an active enzyme. 
Whenever the protein was crystallized with L-Ala-L-Glu or with L-Pro-L-Glu, the 
substrate molecule in the crystal structure was always in the D-Glu configuration. This 
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observation further cements the idea that BT1313 is more specific for the L-Glu 
containing dipeptides. 
 
 
 
Figure 2.34. BT1313 structure solved at 1.6Å resolution. The numbering of the 
active site residues matches that of the predictions. The carboxylate group, however, 
is in the wrong coordination sphere with respect to the metal ion. 
 
The crystal structure that was solved at 2Å resolution exhibits close to normal distances 
from the substrate carboxylate group to the metal ion in the second polypeptide (Figure 
2.35). The first polypeptide in the structure has elongated distances between the substrate 
carboxylate group and the metal ion. Also, in the second active site, the Lys 200 also has 
good orientation to the substrate α-carbon which is too far away in the first polypeptide. 
Arg 68 always has good coordination to the γ-carboxylate group of the L-Ala-D-Glu 
substrate. 
Lys200 
Lys298 
Arg68 
Asp350 
Asp348 
Asp276 
Glu251 
Asp224 
L-Ala-D-Glu 
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Figure 2.35. Active site of the polypeptide B of BT1313 2Å structure. The 
orientation of Lys200 to the substrate α-carbon is good, and the distances between 
the metal ion and the substrate α-carboxylate group are acceptable as well. 
 
Although it is unclear how exactly the substrate specificity is determined for the N-
terminal side of the dipeptide substrate in the case of BT1313, there seems to be an 
elongated pocket above the alanine side chain of the substrate molecule. Perhaps that 
pocket can explain the somewhat relaxed specificity for that position. 
 
Lys200 
Lys298 
Arg68 
Asp350 
Asp 348 
Asp276 Glu251 
Asp224 
L-Ala-D-Glu 
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2.5.1.3. Comparison of the predicted structure with homology model 
 The homology model that was used for virtual library screening was proven 
accurate in that the substrate specificity predictions were correct in broad terms. 
Predictions were confirmed with the ESI-MS assay, showing a relaxed specificity for the 
N-terminal portion of the substrate when the C-terminal amino acid was Glu. Also, the 
protein backbone overlays nicely with the crystal structure, and a comparison of the two 
active sites reveals only minor differences in the orientation of the amino acid side 
chains. (Figure 2.36). 
     
Figure 2.36. Overlay of the BT1313 homology model (blue) and the 2Å crystal 
structure (gold). The estimated RMSD between 247 α-C pairs is 1.14Å. Bound 
ligand is L-Ala-D-Glu from the BT1313 crystal structure. 
 
2.5.2. Cytophaga hutchinsonii dipeptide epimerase 
2.5.2.1. Predicted tertiary structure of the enzyme 
 Although multiple attempts have been made by the Almo group to crystallize this 
dipeptide epimerase, no structure has been solved for the enzyme since its first 
purification in 2007. Attempts to reductively alkylate the enzyme to improve crystal 
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lattice packing [43] yielded even further protein instability and protein concentration 
above 2 mg/mL resulted in heavy precipitation. 
 The homology model for CHU2140 was constructed in Prof. Jacobson’s lab at 
UCSF based on the B. subtilis AEE crystal structure. Although no crystal structure was 
solved for CHU2140, it can be assumed that the homology model was constructed with a 
high level of accuracy. The homology model was used for virtual library screening and 
the results were generally proven correct with in vitro experiments. The CHU2140 
homology model conforms to the classical modified TIM barrel structure and has the 
characteristic bidomain architecture of the enolase superfamily (Figure 2.37).  
 
Figure 2.37. Homology model of CHU2140. Active site residues are color coded as 
previously. The pose has D-Ala-L-Val bound in the active site. 
 
Based on the homology model, the following residues are thought to be important for 
general substrate recognition and catalysis: Lys 162 and Lys 265 are the acid-base 
catalysts; Asp 190, Glu 216 and Asp 241 act as the metal binding ligands; and both Asp 
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318 and Asp 320 and potentially Thr 135 are responsible for the recognition of the α-
ammonium group of the dipeptide substrate. Unlike BT1313 and the previously 
characterized AEE’s, the loop structures of CHU2140 lack residues that would provide 
very specific interactions to the substrate molecule as is the case of Arg 24 and Arg 68 in 
the case of B. subtilis AEE and BT1313, respectively. The loops and the back of the 
active site, however, are lined with residues that would provide the necessary interactions 
for the small hydrophobic substrate recognition (Figure 2.38). 
 
 
Figure 2.38. Stereo view of the CHU2140 homology model. Active site residues have 
been color coded as before. otice Thr135 that can act as a hydrogen bond donor to 
the α-ammonium group of the dipeptide substrate and multiple hydrophobic 
residues in the active site loops. The pose contains D-Ala-L-Val as the ligand. 
 
2.5.3. Homology model as the tool for predicting function 
 Crystal structures are often difficult to obtain. The usual method for overcoming 
bad crystallization properties of a protein is to turn to an orthologous enzyme. In many 
instances, however, when the enzyme is highly divergent, that is not an option. 
Homology modeling has been proven an exceptionally powerful tool to infer structure 
Thr135 Thr135 
Asp320 Asp320 
Asp318 Asp318 
Lys265 Lys265 
Lys162 Lys162 
Asp190 Asp190 
Glu216 Glu216 
Asp241 Asp241 
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based on sequence utilizing the structural information available for a homologous 
enzyme. Although we cannot always verify that the homology model is structurally 
accurate, the enzymatic activity can be confirmed experimentally. In this chapter I have 
shown two additional examples for the utilization of homology models for functional 
assignment. In both cases, the functional assignment based on homology modeling was 
proven correct. 
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CHAPTER 3: ATTEMPTS OF FUCTIOAL ASSIGMET FOR MR 
SUBGROUP MEMBERS FROM Polaromonas sp., Silicibacter sp. AD 
Sinorhizobium meliloti.  
3.1. Background information 
3.1.1. Detailed analysis of the mandelate racemase subgroup 
A more detailed overview of the structural and mechanistic characteristics of 
select mandelate racemase (MR) subgroup members will be given in this section. 
Currently nine functions are known in the MR subgroup, catalyzed by eight different 
enzymes. Although the structural basis for substrate specificity in these enzymes is 
different, the underlying principles that govern how catalysis is achieved, is conserved. 
 
3.1.1.1. Mandelate racemase from Pseudomonas putida 
Mandelate racemase (MR) was the first enzyme discovered in this subgroup and, 
thus, the basis for the name of the subgroup. Although most enzymes in this subgroup are 
involved in the dehydration of acid sugar substrates, MR is involved in the racemization 
of R- and S-mandelate in a pathway that leads to their degradation to benzoic acid. MR 
also plays a historically important role in the establishment of the enolase superfamily. 
After it was recognized that MLE and MR are structurally homologous [15], it soon 
became clear that these enzymes belong to the same superfamily [16]. MR is the most 
studied enzyme in the enolase superfamily. 
MR from P. putida is a 38 kDa protein which forms a tightly packed octamer in 
the crystal structure. The active site architecture between MR and the other MR subgroup 
members is conserved; therefore, only the active sites of MR and L-fuconate (6-deoxy-L-
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galactonate) dehydratase will be discussed. The functions of the active site residues of 
MR were identified through mutagenesis and crystallographic work in the 1990s [44]. 
Lys 166 was determined to be the S-specific base, abstracting the α-proton from S-
mandelate [45]. The R-specific base was identified as His 297, abstracting the α-proton 
from R-mandelate. The pKa of His 297 is modulated by Asp 270; thus, the two residues 
act as a catalytic dyad, reminiscent of the His-Asp dyad that occurs in serine proteases. A 
Glu 317 interacts via a hydrogen bond with the carboxylate group of S-atrolactate 
inhibitor in the crystal structure. Mutagenesis of Glu317 to Gln reduced the kcat by 4.5 x 
103 fold for R-mandelate and 2.9 x 104 fold for S-mandelate. These results suggest a role 
as an electrophilic catalyst [46]. Additionally, Lys 164 was determined to have an 
important role in the stabilization of the enediolate intermediate. The metal binding 
ligands were found to be Asp 195, Glu 221 and Glu 247 (Figure 3.1).  
 
Figure 3.1. Active site structure of MR from Pseudomonas putida with S-atrolactate 
as the ligand (PDB:1MDR). 
 
Lys166 
Asp195 
Glu221 
Glu247 
Asp270 
His297 
Glu317 
Lys164 
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Thus, the reaction proceeds through abstraction of the substrate α-proton via the 
Lys 166 or His 297 base catalyst. The formed enediolate intermediate is stabilized by the 
Mg2+ ion, the ε-amino group of Lys 164 and by the carboxylate side-chain of Glu 317. 
Racemization is achieved via protonation of the enolate intermediate by the Lys 166 or 
His 297 acid-catalyst (Figure 3.2). 
 
 
Figure 3.2. The proposed reaction mechanism for the P. putida mandelate racemase. 
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3.1.1.2. L-Fuconate dehydratase from Xanthomonas campestris 
L-Fuconate dehydratase (FucD) from X. campestris is an example of assigning a 
function utilizing operon context (Figure 3.3) and library screening [29]. The first gene in 
the FucD operon in the NCBI non-redundant database was annotated as L-fucose 
permease (XCC 4071) which is orthologous to the permease in the E. coli L-fucose 
catabolic pathway. E. coli genome, however, does not encode an enolase superfamily 
member that can utilize L-fuconate as substrate. 
 
 
 
 
Figure 3.3. Fucose degradation operon from Xanthomonas campestris. 
 
 It was thus hypothesized that the X. campestris operon is involved in the catabolism of 
L-fucose. Based on the operon context, a novel pathway for fucose degradation was 
proposed (Figure 3.4). The permease in the operon is followed by a mutarotase (XCC 
4070) that can equilibrate between the slow converting α- and β-anomers of L-
fuconopyranoside.  A subsequent oxidoreductase (XCC 4065) can then oxidize L-
fuconopyranoside to L-fuconolactone. A hydrolase (XCC 4066), then cleaves the L-
fuconolactone to L-fuconate that is utilized by the enolase superfamily member (XCC 
4069) that was identified as an L-fuconate dehydratase. The dehydration product, 2-keto-
3-deoxy-L-fuconate, would then be oxidized by the next enzyme (XCC 4067) in the 
pathway to 2,4-diketo-3-deoxy-L-fuconate.  The final enzyme in the pathway was 
annotated as a member of the fumarylacetoacetate hydrolyase (FAAH) superfamily (XCC 
XCC4065     XCC4066     XCC4067        XCC4068      XCC4069     XCC4071 
   XCC4070 
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4068), which was postulated to cleave the oxidized product to pyruvate and L-lactate. 
Due to the lack of expression of soluble protein, functions of some of the enzymes in the 
proposed pathway were not experimentally verified. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4. Proposed pathway for fuconate degradation in X. campestris.  
 
FucD was screened for dehydration activity with a library of 4, 5 and 6 carbon 
mono- and diacid sugars. This yielded a list of possible substrates to be characterized 
kinetically. The best substrate was determined to be L-fuconate with a kcat of 15 s
-1, KM of 
0.33 mM and a kcat/KM of 4.5 x 10
4 M-1s-1. FucD could also catalyze the dehydration of L-
galactonate and D-arabinonate, which have the same stereochemical configuration at 
carbons 2-4 (Figure 3.5). 
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Figure 3.5. In addition to L-fuconate, FucD can dehydrate substrates that have D-
arabino configuration but also epimerize substrates at C2 position with D-ribo 
configuration. 
 
The absolute stereochemical configuration of the α-carbon for L-fuconate is S.  The 
substrates with that configuration were also susceptible to α-proton exchange while the 
substrates with inverted configuration at that position were susceptible to low levels of 
epimerization and dehydration.  
The active site architecture of the TIM barrel portion of FucD is very similar to 
that of MR and contains all conserved residues required for catalysis, including Glu 382 
(homologous to Glu 317 of P. putida MR) which likely serves the role of an electrophilic 
catalyst as described for MR (Figure 3.6). 
The FucD-catalyzed reaction is initiated by abstraction of the α-proton from L-
fuconate, mediated by Lys 220 base-catalyst, followed by the formation of enediolate 
intermediate. The enediolate intermediate then partitions between β-elimination of the 3-
hydroxyl group and C2 protonation to regenerate the substrate. The β-elimination of 
water is mediated by the appropriately positioned His 351 acid-catalyst. Enzyme-
catalyzed ketonization of the enol intermediate is mediated by the conjugate acid of Lys 
220. Dehydration of L-fuconate was determined to proceed with inversion of 
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configuration with the 3-OH group being replaced with solvent derived hydrogen into the 
pro-S position (Figure 3.7). The ability of FucD to catalyze epimerization of D-ribonate 
and L-talonate can be explained by an active site that bears close structural resemblance 
to that of MR. 
 
Figure 3.6. Active site structure of the Xanthomonas campestris L-fuconate 
dehydratase with D-erythronohydroxamate as the ligand (PDB: 2HXT). 
 
 
 
 
 
 
 
 
 
 
Figure 3.7. Proposed reaction mechanism for the X. campestris FucD. The reaction 
proceeds via inversion of configuration with the C3 proton being incorporated into 
the pro-S position. 
Lys220 
Lys218 
Asp248 
Glu274 
Glu301 
Asp324 
His351 
Glu382 
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3.1.2. Challenges for identification of function in the MR subgroup. 
In later portions of this chapter, examples will be provided where operon context 
and library screening alone were not sufficient for functional assignment. The MR 
subgroup is paradoxal in that eight of the nine known enzymes utilize acid-sugar 
substrates. Mandelate racemase, however, utilizes an aromatic carbon acid. This apparent 
irregularity in the type of substrate, however, may indicate that the repertoire used for 
screening is far too small and structurally too homologous. Homology modeling and 
docking have been proven successful in a number cases in the MLE subgroup as 
described in the previous chapter. This, however, may be due to the absolute necessity of 
certain sequence motifs for certain types of substrates (e.g. DxD motif at the end of the 
8th β-strand designates a dipeptide substrate). The sequences in the MR subgroup are very 
divergent and it is unlikely that all of the members in this subgroup catalyze the 
dehydration of various acid-sugar substrates, MR being the prime example of that 
hypothesis. In silico library screening in the context of MR subgroup has proven to be a 
difficult task as well, partly because docking can only predict binding and not actual 
catalytic activity. The library that was used in this chapter consists of only ~65 mono- 
and diacid sugars, which naturally limits the success rate. 
 
3.2. Materials and methods 
3.2.1. Cloning of genes 
3.2.1.1. Cloning of SB61 and SB65 from Silicibacter sp. TM1040 
The genes encoding for a putative FucD (SB61, original gi:52010061, new 
gi:99078367) and for a putative acid sugar dehydratase (SB65, original gi:52010065, new 
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gi:99078371) from Silicibacter sp. TM1040 were amplified from the genomic DNA with 
the following oligonucleotide primers from the complementary strand: 
 
SB61 5’-ACAGAGGCAGCCATATGACCAAGATCACAGGCTTGCGCAC-3’ 
SB61 5’-GATGTGAACTCTCGAGTCAGCCGTCCGAAAACAAGAACGCG-3’ 
 
SB65 5’-GCGTTGAATTGCATATGATCGACCTCAAGCCCAAGGTG-3’ 
SB65 5’-CATTCCCATTCGGATCCTCATGCACCTCCAATGGAGCGC-3’ 
 
Primers for SB61 were designed with &deI and XhoI restriction sites and with &deI and 
BamHI restriction sites for SB65 (in bold). The PCR was carried out as described in 
previous chapter. The PCR products were digested and ligated into pET-17b, pET-15b 
and Tom-15b vectors as described earlier. 
 
3.2.1.2. Cloning of PM36, PM37, PM38 and PM39 from Polaromonas sp. JS666 
The genes encoding a putative FAAH homologue (PM36, original gi:54029036, 
new gi:91789799), putative 2-keto-3-deoxy-L-fuconate 4-dehydrogenase (PM37, original 
gi:54029037, new gi:91789800), a putative oxidoreductase (PM38, original gi:54029038, 
new gi:91789801) and a putative acid sugar dehydratase (PM39, original gi:54029039, 
new gi:91789802) from Polaromonas sp. JS666 were amplified from the genomic DNA 
with the following oligonucleotide primers from the complementary strand: 
 
PM36 5’-CCAGAAGGAAAACATATGAAACTCGTTCGTTATGGCAACC-3’ 
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PM36 5’-GCTACGCGAAGCGCTCGAGCGTGGGGGCTTTATTTC-3’ 
 
PM37 5'-CGACGGCGGCATGACCATATGAACCAGCTTGACCTG-3' 
PM37 5'-GGTTAAATCAAACTCGAGTCAATAAGTCAGTAAGTCGAACGC-3' 
 
PM38 5'-GGCCGGCCAGGATCCGCTGGTTCATATGGTCATG-3' 
PM38 5'-CCATCGTCAACAACCAAGGACTCGAGATGAGACTCC-3' 
 
PM39 5'-CCTGGATACCCTTCTGCCATATGAAACCGGAAGTAACG-3'   
PM39 5'-GTTGTGATGATTGCCTCGAGTTACTTGATGGTCACGTC-3' 
 
The primers for PM36, PM37 PM39 were designed with &deI and XhoI cleavage sites (in 
bold); primers for PM38 were designed with BamHI and XhoI restriction sites (in bold). 
The digested PCR products were ligated into the prepared pET vectors as described 
earlier. 
 
3.2.1.3. Cloning of Smb21107, Smb21108 and Smb21112 from Sinorhizobium meliloti 
1021 
The genes encoding for putative acid sugar dehydratase (Smb21107, 
gi:16264434), an L-fucose mutarotase (Smb21108, gi:16264435) and a putative FAAH 
aldolase (Smb21112, gi:16264439) from Sinorhizobium meliloti 1021 were amplified 
from the genomic DNA with the following oligonucleotide primers: 
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Smb21107  
5’-CTTTGGCAAGCTCATATGGCTAGGATCGAGAAAACAGAACTCCG-3’ 
Smb21107  
5’-CTGCATGACCGTCTCGAGCTACCGGCGGAACTCGCGGG-3’ 
 
Smb21108 5’-CCTGGAAGGGAACGCATATGCAGAGAATGGGAATG-3’ 
Smb21108 5’- CAGCGATGAGGGATCCAATGTCTCAGTCATGGTGG-3’ 
 
Smb21112 5’-CAATCAGGGAAAAGCATATGAAACTTCTTCGTTATGG-3’ 
Smb21112 5’-GGAAACACTCGAGTAGCTCAGGCGTCGGCGC-3’ 
 
The primers for Smb21107 and Smb21112 were designed with &deI and XhoI restriction 
sites (in bold); primers for Smb21108 were designed with &deI and BamHI cleavage sites 
(in bold). The cloning procedures were followed as described earlier. 
 
3.2.1.4. Cloning of Mll7147 and Mll7149 from Mesorhizobium loti MAFF303099 
The genes encoding for a putative L-fucose mutarotase (Mll7147, gi:14026712) 
and a putative acid sugar dehydratase (Mll7149, gi:14026713) from Mesorhizobium loti 
MAFF303099 were amplified from the genomic DNA with the following oligonucleotide 
primers from the complementary strand: 
 
Mll7147 5’-GGCGATCACGAAATAGGAGTCGCATATGCAGCGAATGGGC-3’ 
Mll7147 5’-GGACTGGACGAGTAGGGCAGGCTCGAGACCACCCTCAG-3’ 
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Mll7149 5'-GCGGAGCTGATTAATGGCTAGAATCGAGAAAGTCGAACTG-3' 
Mll7149 5'-GCCCATTCGCTCGAGATCCGACTCCTATTTCGTGATCG-3' 
 
The primers for Mll7147 were designed with &deI and XhoI restriction sites (in bold); 
primers for Mll7149 were designed with AseI and XhoI endonuclease cleavage sites (in 
bold). The AseI endonuclease site was designed due to internal &deI and BamHI 
restriction sites in the Mll7149 gene. The same cloning procedures were followed as 
described earlier. 
 
3.2.1.5. Cloning of Atu3139 from Agrobacterium tumefaciens str. C58 
The gene encoding for a putative acid sugar dehydratase (Atu3139) from 
Agrobacterium tumefaciens str. C58 was amplified from the genomic DNA with the 
following oligonucleotide primers from the complementary strand:  
 
Atu3139 5’-GAAAAACGGGAGGGGACATATGAAAATCACGGCGGTGC-3’ 
Atu3139 5’-CTCAGTTTTCTCTCGAGTTCGCTCATGGGTCTGGCATC-3’ 
 
The primers for Atu3139 were designed with &deI and XhoI restriction sites (in bold). 
Same cloning principles were utilized as described earlier. 
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3.2.2. Purification of proteins 
3.2.2.1. Expression and purification of SB61 and SB65 
 Both SB61 and SB65 were both cloned into an array pET vectors and screened for 
expression as described in the previous chapter. SB65 yielded inclusion bodies; attempts 
to purify the enzyme were abandoned. SB61 expressed well from the pET-15b vector. 
For optimal protein expression, a typical culture was incubated for 36 hours at 20 °C in 
LB medium in the presence of 100 µg/mL of ampicillin. SB61 was purified via His-tag 
affinity chromatography as described in previous chapter. The His-tag was removed by 
incubating the protein at room temperature in the presence of 4 units of thrombin per mg 
of SB61 for 4 days in 1X PBS buffer. The protein was then subjected to anion exchange 
chromatography to separate the protease from the cleaved protein. The purified protein 
was dialyzed against a 50 mM Tris-HCl, pH 8.0, containing 12.5% glycerol, 100 mM 
NaCl, and 5 mM MgCl2. 
 
3.2.2.2. Expression and purification of PM36, PM37, PM38 and PM39 
 Although multiple attempts were made, no protein expression was detected for the 
PM36 aldolase. The expression screening followed the procedure as described in the 
previous chapter. However, PM37, PM38 and PM39 expressed well from the pET-15b 
vector in E. coli BL21 (DE3). For a typical purification, E. coli BL21 (DE3) containing 
PM37 in pET-15b was incubated for 48 hours at 37 °C in LB medium in the presence of 
100 µg/mL of ampicillin. The protein was purified via His-tag affinity chromatography as 
described earlier. The pure protein was stored in 20 mM Tris-HCl, pH 8.0, containing 
101 
 
100 mM NaCl. The same growth conditions and purification practices were also used for 
the PM38 oxidoreductase. Cleavage of the His-tag was never attempted. 
 For a purification of PM39, E. coli BL21 (DE3) containing PM39 in pET-15b was 
incubated at 37 °C for 36 hours in the presence of 100 µg/mL of ampicillin. The His-tag 
was removed as described for SB61. Pure PM39 was dialyzed against 50 mM Tris-HCl, 
pH 8.0, containing 100 mM NaCl, and 5 mM MgCl2 for storage. 
 
3.2.2.3. Expression and purification of Smb21107, Smb21108 and Smb21112 
 Expression screening was carried out as described in the previous chapter. 
Smb21112 showed no detectable expression. Smb21107 expressed well at 37 °C. For 
purification, E. coli BL21 (DE3) containing Smb21107 in pET-17b was incubated at 37 
°C for 16 hours in LB medium in the presence of 100 µg/mL of ampicillin. The protein 
purification followed the protocol that was described for CHU2140 in the previous 
chapter. The pure protein was dialyzed against 50 mM Tris-HCl, pH 8.0, containing 100 
mM NaCl and 5 mM MgCl2 for storage. The identity of the protein was verified via LC-
MS/MS analysis, performed at the University of Illinois Protein Sciences Facility. 
 For purification of Smb21108, E. coli BL21 (DE3) containing Smb21108 in Tom-
15b was incubated at 37 °C for 16 hours. The protein was purified via His-tag affinity 
chromatography as described earlier. The protein was dialyzed against 50 mM Tris-HCl, 
pH 8.0, containing 100 mM NaCl for storage. Removal of the His-tag was not attempted. 
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3.2.2.4. Expression and purification of Mll7147 and Mll7149 
 Mll7147 mutarotase expressed well at 37 °C from the pET-15b vector. Expression 
of the Mll7149 putative acid sugar dehydratase was detected from the pET-17b vector at 
37 °C but purification was not pursued. For a purification of the Mll7147 mutarotase, E. 
coli BL21 (DE3) containing Mll7147 in pET-15b was incubated at 25 °C for 48 hours in 
LB medium in the presence of 100 µg/mL of ampicillin. The incubation temperature of 
25 °C was chosen to improve expression in a large scale culture. The purification 
followed the standard His-tag chromatography protocol described earlier. Removal of the 
His-tag was not attempted. The pure protein was dialyzed against 50 mM Tris-HCl, pH 
8.0, containing 100 mM NaCl for storage. 
 
 3.2.2.5. Expression and purification of Atu3139 
 The Atu3139 putative acid sugar dehydratase was screened for expression as 
described earlier. For purification, E. coli BL21 (DE3) containing Atu3139 in pET-15b 
was incubated for 48 hours at 37 °C in LB medium in the presence of 100 µg/mL of 
ampicillin. The protein was purified as described earlier using the standard His-tag 
affinity chromatography protocol. The pure protein was dialyzed against 50 mM Tris-
HCl, pH 8.0, containing 100 mM NaCl, and 5 mM MgCl2 for storage. 
 
3.2.3. Semicarbazide assay 
 In order to detect acid-sugar dehydration, an assay was employed utilizing the 
reactivity of α-keto acids with semicarbazide [47]. The semicarbazone product has an 
extinction coefficient of 10,200 M-1cm-1 and a λmax of 250 nm (Figure 3.8). It should also 
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be noted that the reaction of semicarbazide with aldehydes was observed during this 
work, giving much higher levels of background absorption to uronic acids. The reaction 
mixtures were quenched with a solution of 1% sodium acetate/semicarbazide and 
incubated for 1 hour; the absorbance at 250 nm was measured. The list of assayed 
compounds is presented in Table 3.1. The acid sugars were incubated with 1 µM enzyme 
for 16 hours to allow for the discovery of partial reactions. 
6-carbon 
monoacids 
4 and 5-carbon 
monoacids 
Diacids Uronic acids 
L-rhamnonate 
D-mannonate 
L-mannonate 
D-talonate 
L-talonate 
D-fuconate 
L-fuconate 
D-glactonate 
L-galactonate 
D-gluconate 
L-gluconate 
D-gulonate 
L-gulonate 
D-idonate 
L-idonate 
D-altronate 
L-altronate 
D-allonate 
L-allonate 
D-arabinonate 
L-arabinonate 
D-xylonate 
L-xylonate 
D-lyxonate 
L-lyxonate 
D-ribonate 
L-ribonate 
D-erythronate 
L-erythronate 
Allarate 
D-glucarate 
L-glucarate 
D-mannarate 
L-mannarate 
Galactarate 
L-idarate 
D-talarate/D-
Altrarate 
L-altrarate/L-
Talarate 
L-arabinarate 
D-arabinarate 
Xylarate 
D-galacturonate 
D-glucuronate 
 
Table 3.1. List of 6-, 5- and 4-carbon mono- and diacid sugars and uronic acids that 
were utilized during the screening process for the enzymes discussed in this chapter. 
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Figure 3.8. Semicarbazide reacts with the α-keto acid to form semicarbazone 
product which has an absorption maximum at 250 nm. Example with L-galactonate 
dehydration. 
 
3.2.4. NMR assay for α-proton exchange and epimerization 
 As described in the previous sections of this chapter, members of the MR 
subgroup have been shown to catalyze low levels of dehydration, exchange of the α-
proton, and epimerization with substrates that are somewhat similar to one-another. Due 
to the small size of the library, an NMR screening approach was utilized to detect both α-
proton exchange and epimerization at C2 to obtain clues as to the nature of the natural 
substrate. Both epimerization and α-proton exchange are undetectable in the 
semicarbazide assay. The assays were carried out in D2O buffer, utilizing pairs of acid 
sugar substrates to reduce the required number of NMR spectra. 
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3.2.5. Coupled enzyme assay for FucD activity 
 L-Fuconate dehydratase activity of SB61 was assayed via a continuous coupled 
spectrophotometric assay as described by Yew et al. [29]. The assay utilized the 2-keto-
3-deoxy-L-fuconate 4-dehydrogenase from Xanthomonas campestris (XCC 4067) to 
reduce the dehydrated 2-keto-3-deoxy-L-fuconate product. The assay contained 50 mM 
K+ Hepes, pH 7.5, 10 mM MgCl2, 1.6 mM NAD
+, 1 mM p-iodonitrotetrazolium violet 
(INTox), 5 units of diaphorase and 10 units of 2-keto-3-deoxy-L-fuconate 4-
dehydrogenase. In the reaction, INTox is reduced and the conversion can be observed at 
500 nm; the molar extinction coefficient for INTred is 12,990 M
-1cm-1. 
 The same assay was utilized to validate the function of PM37 from the 
Polaromonas sp. operon as the 2-keto-3-deoxy-L-fuconate 4-dehydrogenase. NAD+, 
NADP+ and the reduced forms of the two cofactors were utilized in conjunction with 
acid-sugar substrates in failed attempts to decipher the function of PM38. 
 
3.3. Genomic background and preliminary predictions 
Unlike with the members of the dipeptide epimerase family, no homology models 
or in silico predictions for substrate specificity were available for the members in the MR 
subgroup. Clues as to the substrate specificity were thus inferred from operon context and 
the sequence information. 
 
3.3.1. Analysis of multiple sequence alignment 
 Although operon contexts and available crystal structures will be discussed in 
later sections, four of the enzymes (PM39, Smb21107, Mll7149 and SB65) seem to have 
106 
 
some relation to L-fucose degradation.  A sequence alignment was thus generated for 
these four enzymes, Atu3139 and the L-fuconate dehydratases from both X. campestris 
and from Silicibacter sp. (Figure 3.9) using ClustalW.  
First, the L-fucose degradation-related enzymes will be discussed and an analysis 
of similarities and differences between those will be provided. All of the proteins share 
~30% in sequence identity with MR and FucD. 
 All four putative acid sugar dehydratases have a KxK motif at the end of the 2nd 
β-strand; also the three metal binding ligands, Asp, Glu and Glu can be found at the ends 
of 3rd, 4th and 5th β-strands, respectively. The ends of the 7th and 6th β-strands contain the 
His-Asp dyad, placing the enzymes in the MR subgroup. The Glu residue, reminiscent of 
MR, can be found at the end of the 8th β-strand. The identity of the 8th β-strand Glu 
residue, however, was not obvious from sequence and could only be identified after an X-
ray crystal structure was solved for PM39. A major difference between FucD and the 
related proteins is a missing stretch of amino acids that covers positions ~140-180 in the 
FucD sequence. Structurally, that stretch makes up three α-helical structures on the 
outside of the barrel. The structural differences that potentially result in poor kinetic 
constants of L-fuconate dehydration for the related proteins will be discussed in later 
parts of this chapter. 
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Figure 3.9. Multiple sequence alignment of Atu3139, PM39, Smb21107, Mll7149, 
SB65, SB61 (FucD) and Xanthomonas campestris FucD. 
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The sequence of Atu3139 contains all of the residues necessary to place it into the MR 
subgroup. It is also about the same length as MR and also lacks the stretch of amino acids 
that are present at positions ~140-180 in the FucD structure. The 20s and 50s loops 
sequences are divergent as well, suggesting a novel substrate specificity. 
 
3.3.2. Genomic context 
 The operon context for Atu3139 will be discussed first. There are a total of eight 
genes in the proposed operon (Figure 3.10). The gene spacing for two genes, however, is 
>100 bp, making it difficult to judge if the genes in this stretch of the genome form an 
operon. First, three genes in the operon (Atu3135, Atu3136 and Atu3137) are a part of a 
small-molecule uptake system that is homologous to ATP independent C4-dicarboxylic 
acid transporters [48]. The next gene, Atu3138, is a member of the amidohydrolase 
superfamily, potentially catalyzing the hydrolysis of a lactone ring. Atu3139 is the 
putative acid sugar dehydratase. Atu3140, the next gene, is annotated as a member of the 
dihydropicolinate synthase superfamily, enzymes known to catalyze aldolase reactions. 
The last two genes are annotated as 2-deoxy-D-gluconate-3-dehydrogenase (Atu3140) 
and 5-dehydro-4-deoxy-D-glucuronate isomerase (Atu3141), respectively. This operon 
could thus be a part of a pathway that catabolizes either a dicarboxylic or a uronic acid 
substrate. 
  
 
 
Figure 3.10. Operon structure of the putative acid-sugar dehydratase, Atu3139. 
Gene spacings in base pairs are indicated above the genes. 
Atu3135     Atu3136    Atu3137    Atu3138            Atu3139         Atu3140    Atu3141   Atu3142 
∆0     ∆70       ∆143      ∆−4                          ∆25            ∆113         ∆−3 
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Although the operon context for Atu3139 is complex, the nature of the next set of 
enzymes is even more puzzling. The last chapter will deal with the E. coli D-glucarate 
degradation operon, which in addition to glucarate dehydratase (GlucD), contains a 
second enolase superfamily member that is a close homologue of GlucD. However 
glucarate dehydratase related protein (GlucDRP) has no clear role and is impaired in the 
GlucD activity. A similar example can be found in the case of the operons that utilize L-
fucose in Silicibacter sp. and Sinorhizobium meliloti. In addition to the functional L-
fuconate dehydratase (FucD), the operons also encode an additional MR subgroup 
member (SB65 and Smb21107) that share ~30% in sequence identity to the FucD. 
Strikingly, Mesorhizobium loti and Polaromonas sp. operons lack the FucD and contain 
only the unknown MR subgroup member (Mll7149 and PM39), alongside with other 
genes required for L-fucose catabolism. The operon structures for the four enzymes can 
be found in Figure 3.11. 
 
3.3.3. Phylogenetic profiling 
 As was mentioned previously, the MR subgroup members in this chapter share 
only ≥30% in sequence identity to previously characterized enolase superfamily 
members. A sequence relatedness diagram was constructed in Prof. Patricia Babbitt’s lab 
at UCSF. Figure 3.12 displays the MR subgroup members that group together at a blast 
expectation value of e-60. The L-fucose degradation related MR subgroup members form 
a cluster (circled in red) that is most closely related to the previously characterized L-
talarate/galactarate dehydratase (the cluster to the left on the diagram) and to a cluster of 
enzymes (the cluster to the right on the diagram) that have a partial D-galacturonate  
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dehydration activity (Dr. John Rakus, unpublished results). Strikingly, D-galacturonate 
has the same overall stereochemical configuration at carbons 2 to 5 with L-fuconate. That 
divergent group also shares ~35% in sequence identity to the L-fucose degradation 
related MR subgroup members. 
 
Figure 3.12. Sequence relatedness diagram of the MR subgroup members at blastp 
expectation value of e-60. Validated functional assignments are color-coded; 
uncharacterized/unvalidated members are represented in gray. 
 
Atu3139 clusters with a small clade of enzymes (circled in blue) that, to date, have no 
known function, thus providing no clues as to the potential function of Atu3139. 
Smb21107 
SB65 
PM39 
Mll7149 
MR 
TalrD 
GalrD 
FucD 
RhamD 
AraD 
ManD 
GalD 
GlcD 
Atu3139 
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3.4. Identification of partial acid-sugar dehydratase activity 
3.4.1. Screening for acid sugar libraries for dehydration activity 
 Screening for acid sugar dehydratase activity was carried out as described in the 
Materials and Methods section unless stated otherwise. 
 
3.4.1.1. Results for Smb21107 and PM39 
In addition to the compounds listed in the Materials and Methods section, 
Smb21107 was screened for dehydration against a library that also contained D-, L- and 
meso-tartrate but was missing L-ribonate. The composition of the library has changed 
over time, therefore depending on when the enzymes were purified, minor changes to the 
library were possible as well. In an overnight incubation, partial dehydration was 
observed for L-galactonate, L-fuconate, D-galacturonate and D-arabinonate. 
Semicarbazide assay was also carried out with PM39 and identical results were obtained. 
Both orthologs have the same apparent stereochemical preference for substrates (Figure 
3.13). The screening library for PM39 included L-ribonate, but was missing D-, L- and 
m-tartrate. 
 
Figure 3.13. The overall stereochemistry at carbons 2-5 is the same for all 
substrates.  
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In addition to the substrates that were utilized for screening, additional screening 
was carried out for PM39 with a mixture of glucuronate/fructuronate and 
galacturonate/tagaturonate. No dehydration was detected for the glucuronate/fructuronate 
mixture. For the galacturonate/tagaturonate mixture, the experiment was set up in parallel 
with 10 mM galacturonate, while the galacturonate/tagaturonate mix contained 
approximately 10 mM of each. Because similar amounts of dehydration product were 
detected, it was assumed that D-galacturonate was the only uronic acid dehydrated in the 
mix. 
 
3.4.1.2. Screening results for Atu3139 
 Although multiple attempts were made to detect dehydration of any of the 
compounds in the library, no positive results were observed. Apparent dehydration was 
observed for L-mannarate, D-idarate and D-talarate, but longer incubation times revealed 
no progression in the course of the reaction, and the dehydration activity was deemed as a 
false-positive. The three substrates are also structurally dissimilar making the dehydration 
of all three very unlikely (Figure 3.14). 
 
Figure 3.14. Structurally dissimilar L-mannarate, D-idarate and D-talarate 
substrates. 
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3.4.2. Acid sugar dehydration kinetics  
 Kinetic constants for the SB61 L-fuconate dehydratase were determined via the 
spectrophotometric coupled enzyme assay. The dehydration kinetics for Smb21107 and 
PM39 were determined with semicarbazide end-point assay. 
 
3.4.2.1. Results for SB61 
 The dehydration kinetics were determined with the recombinantly expressed 6-
His tagged SB61 enzyme. FucD from X. campestris can dehydrate structurally similar 
substrates with lowered rate constants. Our goal, however, was to confirm the validity of 
the SB61 function (inferred from sequence homology); thus only L-fuconate was 
assayed. SB61 was confirmed to dehydrate L-fuconate with a kcat of 4.1 s
-1, KM of 5.3 x 
10-4 M and kcat/KM of 7.7 x 10
3 M-1s-1. These numbers are in good agreement with the 
kinetic constants previously determined for the X. campestris  FucD (kcat of 15 s
-1, KM of 
3.3 x 10-4 M and a kcat/KM of 4.5 x 10
4 M-1s-1) [29]. The decreased kcat value for SB61 
may be explained by the presence of the N-terminal 6-His tag which was not 
proteolytically removed for the enzyme that was utilized for the assay. 
 
3.4.2.2. Results for Smb21107 and PM39 
Only apparent first-order rate constants at 10 mM were determined for 
Smb21107. The best kcat
app for Smb21107 was recorded for D-galacturonate with 1.9 x 
10-2 s-1. 
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For PM39, the best KM value was determined to be 2.6 x 10
-4 M for L-fuconate, 
whereas the best kcat was determined to be 2.5 x 10
-2 s-1 for D-galacturonate. The 
dehydration of D-galacturonate was also verified via NMR in the presence of 50 mM 
Tris-DCl, pD 8.0, and 10 mM MgCl2 (Figure 3.15).  
 
 
 
Figure 3.15. 1H MR of the dehydration product of D-galacturonate. Top panel: 
starting material; bottom panel: dehydrated product.  
 
The complete list of kinetic constants for both PM39 and Smb21107 can be found 
in Table 3.2. The possible meaning of these values will be discussed in later parts of this 
chapter.  
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 Substrate KM (M) kcat (s
-1) kcat/KM (M
-1s-1) kexc (s
-1) 
PM39 L-fuconate 2.6 x 10-4 7.1 x 10-4 2.7 5.6 x 10-3 
 L-galactonate 7 x 10-4 4.6 x 10-4 0.7 1.2 x 10-2 
 D-arabinonate 1.3 x 10-3 4.2 x 10-4 0.3 1.6 x 10-2 
 D-galacturonate 2.5 x 10-2 3.9 x 10-2 1.5 2.3 x 10-2 
 D-altronate - - - 6 x 10-3 
*Smb21107 L-fuconate  8.1 x 10-3  1.76 x 10-2 
 L-galactonate  4.2 x 10-3  Too slow 
 D-arabinonate  1.5 x 10-3  Too slow 
 D-altronate  -  Too slow 
 D-galacturonate  1.9 x 10-2  Not 
measured 
 
Table 3.2. Kinetic constants as determined via the semicarbazide end-point assay. 
For Smb21107, only apparent first order rate constants at 10 mM substrate 
concentration are reported. The α-proton exchange rates were measured via MR 
in the presence of 30 µM enzyme in D2O buffer. 
 
3.4.3. Mutarotase activity 
 Monosaccharides typically exist as cyclized pairs of α- and β-anomers in 
solution. However, the rate of interconversion between the anomeric states is very slow 
(0.015 min-1 for glucose) [49]. In living cells, however, only one anomeric form of the 
sugar is usable, making mutarotase of great physiological significance. A method 
developed by Ryu et al. [49] was thus adapted to the Varian NMR system by a previous 
lab member [29] to observe the interconversion kinetics of the anomeric protons of an 
aldose sugar. The method takes advantage of the change in chemical environment in the 
presence of mutarotase. When one anomeric proton is saturated, the saturation will not 
transfer to the other anomeric proton. When the mutarotase is present, however, rapid 
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change in the chemical environment will result in the saturation transfer from one 
anomeric proton to the other. This can also be characterized kinetically by series of 
equations as described by both Ryu et al. and Yew et al. [29, 49]. 
 
3.4.3.1. Results for Smb21108 
 Our goal was to confirm the validity of the Smb21108 function as an L-fucose 
mutarotase. Saturation difference (SD-NMR) experiments were conducted and it was 
determined that Smb21108 is specific for L-fucose. SD-NMR experiments were also 
carried out with L-galactose, D-arabinose, L-talose, D-ribose and D-galacturonate. When 
the H1 proton of the α-L-fuconopyranoside was irradiated in the presence of Smb21108, 
saturation transfer to the H1 β-anomeric proton was observed (Figure 3.16). Due to the 
partial D-galacturonate dehydration activity of Smb21107, it was hypothesized that the 
mutarotase would also facilitate in the interconversion of the four possible hemiacetals of 
that sugar. This, however, was proven not to be the case.  
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Figure 3.16. SD-MR experiment including the anomeric mixture of L-
fuconopyranosides in the presence of Smb21108 mutarotase. Asterisk denotes the 
H1 α-anomeric proton to be irradiated. The relative intensity of the H1 proton of 
the β-L-fuconopyranoside decreased by 34% in the SD-MR experiment in the 
presence of Smb21108 mutarotase. 
 
3.4.4. α-Proton exchange kinetics 
In order to better understand the function of PM39 and Smb21107, apparent first-
order deuterium exchange rates for the α-proton of a select number of substrates were 
determined. Substrates were chosen based on the results from the semicarbazide assay. 
The rate of exchange (kexc) of the α-proton of the substrate was calculated from the 
following equation, which takes into account the total amount of the substrate bound at 
any time: 
BTobsexc substratesubstratekk ]/[][=  
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Where kobs is the observed first-order rate constant, [substrate]T is the total substrate 
concentration, and [substrate]B is the concentration of enzyme bound substrate. Because 
the concentration of substrate (2 mM) is much greater than the enzyme concentration (30 
µM), the concentration of bound substrate was equal to the enzyme concentration [29]. 
 
3.4.4.1. Results for PM39 and Smb21107 
 The exchange rates, Table 3.2, are faster for all substrates when compared to the 
rates of dehydration. These results suggest improper or loose binding of the substrate. In 
case of the X. campestris FucD, the rate of α-proton exchange for L-fuconate is about 5-
fold slower when compared to the dehydration. Obtaining an accurate rate of exchange 
for D-galacturonate posed a challenge, due to the presence of both α- and β-D-
galacturonopyranoside; thus the sum of the two exchange rates was used (kexc = 2.3 x 10
-2 
s-1 for PM39) which is seemingly slower than the rate of dehydration (Figure 3.17). The 
latter is likely due to the sub-saturating substrate conditions of the assay. No 
epimerization was detected for any of the substrates. Interestingly, PM39 is capable of α-
proton exchange with D-altronate which shares the same stereochemical configuration at 
carbons 2, 3 and 4 with L-fuconate. The inverted configuration at carbon 5 seems to 
completely abolish the enzyme’s ability to dehydrate the substrate. 
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Figure 3.17. 1H MR array experiment to determine the α-proton exchange rate for 
PM39 with D-galacturonate. Top panel: control spectra of D-galacturonate at time 
zero; bottom panel: each slice in the array corresponds to 2.19 minutes. The 5α and 
5β protons belong to the α-protons of the α- and β-D-galacturonopyranoside [50]. 
 
3.4.5. Discussion 
3.4.5.1. Partial acid-sugar/uronate dehydratase activity of PM39 and Smb21107 
 Efforts were made to determine the natural function for both enzymes by 
screening acid-sugar/uronic acid libraries, by utilization of genomic context information 
and by elucidation of the functions of individual enzymes in their operons. Multiple 
enzymes were cloned from the respective genomic DNAs, expressed recombinantly and 
purified to homogeneity. Protein instability and solubility issues were encountered with 
enzymes from all operons from the selected organisms. This is partially the reason why  
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complete coverage of any single operon was not achieved. Both PM39 and Smb21107 are 
in operons with enzymes that are involved in L-fucose degradation. Not surprisingly, 
both enzymes also show distinct stereochemical preference towards substrates that 
resemble L-fuconate at carbons 2-5. Even though the enzymes do not catalyze the FucD 
reaction at rates that would be physiologically relevant, it is possible that they are still 
involved in L-fucose degradation. Possible explanations as to the poor kinetic constants 
include the requirement for the formation of heteromultimeric complexes with other 
enzymes in the operon. One can hypothesize that the formation of such a complex can 
result in “allosteric” activation of the enzyme. The formation of heterodimeric species 
between amidohydrolase superfamily members has been reported in the past. No 
examples for this, however, have been reported for the enolase superfamily. A novel 
example for the formation of a heterodimeric species between two enolase superfamily 
members (GlucD and GlucDRP) will be discussed in the next chapter. The example of 
GlucD and GlucDRP, however, involves proteins that are highly homologous (~70% in 
sequence identity) whereas PM39 and Smb21107 share only a modest ~35% in sequence 
identity to the known FucDs. 
 
3.4.5.2. L-Fuconate dehydratase activity of SB61 
 The gene encoding for a putative FucD was cloned from the genomic DNA of 
Silicibacter sp., expressed recombinantly and purified to homogeneity. The protein was 
kinetically characterized via a spectrophotometric coupled enzyme assay. The rates of L-
fuconate dehydration were comparable to the X. campestris FucD. SB61 is in an operon 
with SB65, an orthologue of PM39, Smb21107 and Mll7149. The operon for this enzyme 
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contains multiple previously uncharacterized enzymes, providing an alternate mechanism 
for L-fucose catabolism. 
 
3.5. Crystal structures 
3.5.1. Silicibacter sp. TM1040 SB61 L-fuconate dehydratase 
  A crystal structure was solved for the SB61 FucD at 2.1 Å resolution by Prof. 
Steven Almo’s lab at AECOM. The crystal structure contains two identical polypeptides 
that are arranged into an N-terminal α + β capping domain and the C-terminal (β/α)7β-
barrel domain. Like the case of the X. campestris FucD, most of the SB61 active site is 
made up of residues from one polypeptide. Trp 99 from the capping domain of the 
symmetry-related polypeptide chain of the dimer completes the active site by 
contributing to the binding pocket for the methyl group of L-fuconate. The active site 
contains D-erythronohydroxamate, an enolate intermediate analogue, as the bound ligand. 
The active sites of SB61 and X. campestris FucD are conserved (Figure 3.18). 
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Figure 3.18. Active site from the 2.1 Å crystal structure of the SB61 FucD. Trp99 of 
the capping domain from one symmetry-related polypeptide completes the binding 
pocket of the methyl group of L-fuconate in the other polypeptide. 
 
3.5.2. Polaromonas sp. PM39 enzyme 
 A crystal structure of PM39 containing L-fuconate was solved by Prof. Steven 
Almo’s lab at 1.6 Å resolution. The crystal structure contains two identical polypeptides 
which conform to the bidomain TIM-barrel fold. The 20s loop that extends from the N-
terminal capping domain, however, is disordered in one of the polypeptides and swung 
open above the active site of the other symmetry-related polypeptide of the dimer. The 
bound ligand, L-fuconate, is coordinated to the Mg2+ ion through only one of the 
carboxylate oxygens and the 5-hydroxyl group of the substrate. In addition, the catalytic 
base (Lys 171) points away from the substrate α-carbon (distance from the α-carbon is 
Lys218 
Lys216 
Asp246 
Asp272 
Asp299 
His349 
Asp322 
* Trp99 
Asp24 
Ile54 
Tyr32 Pro30 
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~6 Å); the active site is filled with water molecules. It is thus safe to assume that such 
substrate coordination represents an inactive enzyme (Figure 3.19). 
     
Figure 3.19. The 1.6 Å crystal structure of PM39 with L-fuconate (and 2-methyl-2,4-
pentanediol) bound in the active site; A) polypeptide A of the crystal structure; note 
the 20s loop in open conformation above the active site; B) active site of PM39, note 
the unusual substrate coordination to the metal ion and the water molecules. The 
structural homologue of Trp99 from FucD is replaced with an alanine residue (red). 
 
A structure-based sequence alignment of SB61 (FucD) and PM39 reveals only two 
conserved residues between the two enzymes in the 20s loop. From the same alignment, 
one can clearly see the void that is present in the top part of the PM39 active site (in place 
of Trp 99), an incomplete binding pocket for the 6-methyl group of L-fuconate. The 
structural homologue of that tryptophan residue is a much smaller Ala 95 moiety, which 
may indicate a longer than a 6-carbon substrate. This incomplete binding site may also be 
one of the explanations for the poor kinetic constants exhibited for L-fuconate 
dehydration and raise the question of the proper interaction partners for the enzyme. One 
can hypothesize a more active enzyme if all the correct protein-protein interaction 
partners are present, bearing in mind that L-fuconate is the true substrate of PM39. 
A.           B. 
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CHAPTER 4: IVESTIGATIO OF E. coli D-GLUCARATE DEHYDRATASE 
AD ITS RELATED PROTEI. 
4.1. Background information 
4.1.1. D-Glucarate dehydratase from Escherichia coli K-12 MG1655 
 Glucarate dehydratase, GlucD, is a member of the enolase superfamily and 
belongs to its own subgroup. Initially, it was classified as a member of the MR subgroup 
due to the presence of the catalytic His-Asp dyad. It was later decided that the unusual 
asparagine metal binding ligand at the end of the 5th β-strand is unique only to the 
GlucDs and, therefore, deserves its own subgroup. In most organisms, GlucD is in an 
operon with a close homologue, which in E. coli shares 62% sequence identity to the 
GlucD, glucarate dehydratase related protein (GlucDRP). In addition to GlucDRP, the 
operon also contains a gene that encodes for D-glucarate transporter. Additional enzymes 
required for glucarate catabolism are encoded by a different region of the E. coli 
chromosome and are also involved in galactarate degradation [51].  
The pathway in which D-glucarate is catabolized utilizes the sequential action of 
5-keto-4-deoxy-D-glucarate (5-KDG) aldolase which cleaves the dehydration product of 
glucarate to tartronate semialdehyde and pyruvate [51] (Figure 4.1). Tartronate 
semialdehyde is reduced to D-glycerate by tartronate semialdehyde reductase (TSAR). 
Finally, D-glycerate is phosphorylated by glycerate kinase to yield 3-phosphoglycerate 
(3-PGA). The final products of the pathway are thus pyruvate and 3-PGA. An alternate 
pathway for glucarate catabolism to α-ketoglutarate in Pseudomonas putida and Bacillus 
subtilis utilize the sequential actions of GlucD, 5-KDG dehydratase/decarboxylase and α-
ketoglutarate semialdehyde dehydrogenase [36, 52]. 
126 
 
 
Figure 4.1. D-glucarate degradation pathway in E. coli K-12. Final products of the 
pathway are pyruvate and 2-PGA. 
 
 Both, the reaction mechanism and crystal structure for the E. coli GlucD are 
known. The active site resides at the barrel-capping domain interface, as is the case for all 
other enolase superfamily members. The acid-base catalyst for D-glucarate dehydration 
was determined to be His 339 of the His-Asp dyad at the ends of the 7th and 6th β-strands. 
In addition to its ability to catalyze dehydration of D-glucarate, GlucD also can epimerize 
D-glucarate at the C5 position, subsequently catalyzing the epimerization and 
dehydration of an unnatural L-idarate substrate [51]. The general acid-base catalyst for 
the epimerization reaction was determined to be Lys 207 at the end of the 2nd β-strand. 
The three metal binding ligands were determined to be Asp 235, Glu 260 and the unusual 
Asn 289. The coordination of Asn 289 to the Mg2+ ion is achieved through the carbonyl 
oxygen of that residue [53]. Depiction of the GlucD active site can be found in Figure 
4.2. 
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Figure 4.2. Active site of E. coli GlucD with bound substrate analog 4-deoxy-D-
glucarate. ote the coordination of the Mg2+ ion to the carbonyl oxygen of Asn 289 
(PDB: 1ECQ). 
 
For the dehydration of D-glucarate, the reaction mechanism proceeds through α-
proton abstraction via the His 339 base-catalyst and formation of the Mg2+-stabilized 
enediolate intermediate. The reaction can then progress via two pathways. In one 
pathway, His 339-assisted vinylogous elimination of the C4 hydroxyl group will occur. In 
the alternate pathway, a proton is accepted from the opposite face of the enediolate 
intermediate, assisted by the Lys 207 acid-catalyst, resulting in the formation of the C5 
epimer, L-idarate. Similarly, the α-proton of L-idarate can be abstracted by the Lys 207 
base-catalyst, resulting in the formation of enediolate intermediate, which can undergo 
either dehydration at C4 or epimerization at C5 to form D-glucarate. However, the 
product of the GlucD reaction is 5-KDG in either case (Figure 4.3). This chapter will 
explore some of the aspects of GlucD and GlucDRP that have not been investigated in 
the past.  
Lys207 
Asp235 
Glu260 
Asn289 
His339 
Asp313 
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Figure 4.3. The proposed reaction mechanism for the E. coli D-glucarate 
dehydratase.  
 
4.2. Materials and methods 
4.2.1. Cloning of genes 
4.2.1.1. Cloning of the gene encoding E. coli GlucDRP 
 The gene encoding for GlucDRP (gi:16130695) from Escherichia coli strain K-12 
substrain MG1655 was amplified from genomic DNA with the following oligonucleotide 
primers from the complementary strand: 
 
5’–CCTGTTGCGGGGCAATCATATGGCGAC–3’ 
5’–CATATTTATGTCCTTCTCGAGAATCAATGAC–3’ 
 
The primers were designed with &deI (forward) and XhoI (reverse) endonuclease 
cleavage sites (bold). The gene was amplified and ligated into prepared pET-17b, pET-
15b and Tom-15b vectors as described earlier. 
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4.2.1.2. Site-directed mutagenesis of E. coli GlucD 
 Site-directed mutants of GlucD were generated using the QuickChange method of 
PCR-mediated mutagenesis. Three pairs of mutant primers were designed. The mutations 
were designed for the 20s and 100s loops of GlucD to imitate those of GlucDRPs. The 
mutations were introduced into the GlucD in pET-16b vector with the following 
oligonucleotide primers: 
 
GlucD S29G 5’-CAGTATGCTGATGAATCTGGGTGGTGCACACGCACCGTTC-3’ 
GlucD S29G 5’-GAACGGTGCGTGTGCACCACCCAGATTCATCAGCATACTG-3’ 
 
GlucD P34A 5’-GGTGCACACGCAGCGTTCTTTACGCGTAATATTGTG-3’ 
GlucD P34A 5’-CACAATATTACGCGTAAAGAACGCTGCGTGTGCACC-3’ 
 
GlucD Q102W 5’-GCTGGTGGGCGCGGTTTGTGGACATTTGACCTACGTACC-3’ 
GlucD Q102W 5’-GGTACGTAGGTCAAATGTCCACAAACCGCGCCCACCAGC-3’ 
 
The mutated codons are highlighted in yellow with the mutations in red. The mutations 
were introduced via PCR using Pfu Ultra™ HF DNA polymerase (Stratagene). The PCR 
amplification mixture (50 µL) contained 0.3 µL of 322 ng/µL template DNA (GlucD in 
pET-16b), 5 µL of 10× Pfu Ultra™ HF buffer, 1 µL of 20 mM dNTP mix, 1 µL of each 
150 ng/µL forward and reverse primer, 1 µL of 2.5U/µL Pfu Ultra™ HF DNA 
polymerase. The PCR was performed on a PTC-200 Peltier Thermal Cycler by the 
following program: 95° C for 0.5 min followed by 18 cycles of 94° C for 0.5 min, 55° C 
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for 1 min, 68° C for 13 min. To eliminate the template DNA, the PCR product was 
digested with DpnI restriction endonuclease for 16 hours. The excess salt in the ligation 
mixture was removed by dialysis against ddH2O using a 0.025 µm filter for a minimum 
of 15 minutes before being electroporated (1.8V, 25 µFD, 200 Ω) into XL1Blue cells. 
Cells were plated onto LB agar plates in the presence of 100 µg/mL ampicillin and 
incubated overnight at 37° C. A single colony was chosen to be sequenced from each 
plate to verify the presence of the mutation. The double (S29G P34A) and triple (S29G 
P34A Q102W) mutants were generated via the same procedure. 
 
4.2.2. Purification of proteins 
4.2.2.1. Purification of E. coli GlucD/GlucDRP heterodimer 
 For the purification of wild-type GlucD/GlucDRP heterodimer (GlucD/DRP), E. 
coli K-12 substrain MG1655 was grown on minimal media utilizing D-glucarate as the 
sole carbon source according to Hubbard et al. [51]. The cells were harvested via 
centrifugation and suspended in a 20 mM Tris-HCl, pH 8.25, containing 5 mM MgCl2. 
The cells were lysed via sonication as described in previous chapters. The insoluble cell 
debris was removed via centrifugation. Cleared cell lysate was applied on a DEAE 
column (2.5 cm × 50 cm) and purified as described earlier. Fractions containing GlucD 
activity were identified with the semicarbazide assay; the units of activity were recorded 
(Figure 4.4).  
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A. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B.  
Column Fractions with activity Units Protein 
Crude lysate (2L culture)  150 GlucD and GlucD/RRP 
DEAE 41-51 110 GlucD and GlucD/DRP 
Phenyl Sepharose 56-60 80 GlucD 
 65-67 9 GlucD/DRP 
Nickel 47-49 7 GlucD/DRP 
 
Figure 4.4. A) Flow chart of a typical purification of GlucD/GlucDRP heterodimer; B) An 
example of the recorded activities from the first three purification steps as determined via 
the semicarbazide end-point assay. Based on a kcat of 20 s
-1, the specific activity for GlucD 
was determined to be approximately 24 U/mg. 
10 mL starter culture of 
E. coli K-12 substr 
MG1655 in LB medium. 
2 L culture in M9 
minimal medium with D-
glucarate (20 mM) as the 
sole carbon source. 
Inoculate, grow 
to OD600 > 1.0. 
Harvest cells via 
centrifugation. 
Lyse cells via 
sonication. 
Clear cell lysate via 
centrifugation. 
Quantitate units of 
GlucD activity via 
semicarbazide assay. 
Separate lysate on DEAE 
anion exchange column. 
Assay fractions. 
Quantitate. 
SDS-PAGE. 
Separate activity 
containing fractions on 
Phenyl Sepharose 
column. 
Assay fractions. 
Quantitate.  
SDS-PAGE. 
Separate the later activity 
containing fractions 
(heterodimer) on ickel 
column. 
Concentrate active 
fractions to <4 mL, 
separate on Gel Filtration 
column. 
Assay fractions. 
Quantitate.  
SDS-PAGE. 
Dilute active fractions 10-
fold to avoid the need for 
dialysis. Separate on 
Resource-Q anion 
exchange column. 
Assay fractions. 
Quantitate.  
SDS-PAGE. 
Set aside the earlier GlucD 
activity containing 
fractions (homodimer). 
ESI-MS of GlucD/DRP 
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The fractions containing GlucD activity were then applied onto a Phenyl Sepharose 6FF 
column in 0.5M (NH4)2SO4 and purified as described in earlier chapters. The fractions 
were assayed for GlucD activity; units of activity were recorded. In this step, due to the 
difference in surface hydrophobicity, the GlucD homodimer and GlucD/DRP heterodimer 
were separated; the units of activity were recorded for both species. Thus, on an SDS-
PAGE, GlucD homodimer was detected as a single band and the heterodimer was 
detected in a double banded pattern (Figure 4.5). 
 
Figure 4.5. An example of GlucD/DRP separation from a Phenyl Sepharose 
purification. Fractions 44-47 and 50-52 contain GlucD activity. 
 
It was estimated that ~10% of GlucD was present as the heterodimeric species. In order 
to achieve homogeneity, fractions containing the heterodimer were applied to a Nickel 
Chelating Sepharose FF column (1.6 cm x 40 cm). All unbound protein was washed off 
with 100 mL of Bind buffer. The protein was eluted with 400 mL with a gradient of 0-
25% Elute buffer; 10 mL fractions were collected. Fractions containing the GlucD 
activity were concentrated to a <4 mL volume and applied to a Superdex 200 (GE 
Healthcare) gel filtration column (2.6 cm x 100 cm). The protein was eluted with 20 mM 
Tris-HCl, pH 7.9, containing 5 mM MgCl2 and 100 mM NaCl; 10 mL fractions were 
collected. Fractions containing the desired activity were diluted 10-fold with ddH2O to 
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decrease the concentration of salt and applied on a Resource Q (GE Healthcare) column 
(1.6 cm x 10 cm) to achieve homogeneity. The column was washed with 100 mL of 20 
mM Tris-HCl, pH 7.9, containing 5 mM MgCl2; GlucD/DRP heterodimer was eluted 
with a linear gradient (400 mL) of 0-300 mM NaCl in 20 Tris-HCl, pH 7.9, containing 5 
mM MgCl2. The protein was dialyzed into 50 mM Tris-HCl, pH 7.9, containing 100 mM 
NaCl and 5 mM MgCl2 for storage. 
 
4.2.2.2. ESI-MS of E. coli GlucD/DRP heterodimer 
 GlucD and GlucDRP differ by 291 Da in molecular weight. However, the 
difference in size as judged by SDS-PAGE seems much larger. The presence of GlucDRP 
in the heterodimeric complex was thus verified via ESI-MS. The observed mass 
difference as detected by ESI-MS was 289 Da which is in good agreement with the 
predicted molecular weight difference of 291 Da (Figure 4.6). 
 
Figure 4.6. ESI-MS of the GlucD/DRP heterodimeric species as eluted from the 
Phenyl Sepharose column. The two detected protein species are likely GlucD (exp: 
49,009; obs: 49,007 Da) and GlucDRP (exp: 48,718; obs: 48,718). 
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4.2.2.3. Purification of E. coli GlucD 
 GlucD was expressed from the pET-16b vector in E. coli BL21 (DE3) in LB 
medium in the presence of 100 µg/mL of ampicillin for 36 hours at 37 °C. Cells were 
harvested by centrifugation and lysed as described in earlier chapters. The protein was 
purified via His-tag affinity chromatography as described in earlier chapters. The protein 
was dialyzed into 20 mM Tris-HCl, pH 7.9, in the presence of 100 mM NaCl and 5 mM 
MgCl2. The His-tag was removed via incubating the enzyme with 50 µg of Factor Xa per 
40 mg of protein for 48 hours at ~25 °C. The His-tag and the Factor Xa protease were 
removed by binding the cleavage mixture in Binding buffer to the Chelating Sepharose 
column and eluting with a 0-25% gradient of Elute buffer as described in previous section 
for the preparation of the heterodimeric species. The cleaved protein was dialyzed into 20 
mM Tris-HCl, pH 7.9, containing 100 mM NaCl and 5 mM MgCl2 for storage. 
 
4.2.2.4. Purification of E. coli GlucDRP 
 GlucDRP was expressed from the Tom-15b vector in E. coli BL21 (DE3) in LB 
medium in the presence of 100 µg/mL of ampicillin for 36 hours at 37 °C. Cells were 
harvested by centrifugation and lysed as described earlier. The protein was purified via 
His-tag affinity chromatography as described earlier. The His-tag was removed with 
thrombin as described in earlier chapters. The protease and His-tag were removed as 
described in earlier chapters. The protein was dialyzed into 20 mM Tris-HCl, pH 7.9, 
containing 100 mM NaCl and 5 mM MgCl2 for storage. 
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4.2.2.5. Attempts of reconstituting GlucD/GlucDRP heterodimer in vitro  
Preliminary attempts for the heterodimer reconstitution in vitro failed. 
Recombinantly expressed GlucD and GlucDRP were purified from E. coli BL21 (DE3) 
in pET-16b and Tom-15b as described above. His-tags were removed for both proteins as 
described above. In order to reconstitute the heterodimeric species, 1:1, 1:3 and 3:1 ratios 
of GlucD and GlucDRP were mixed in the presence of either 0.5 or 1 M of Urea or 
GdnHCl for 1, 3, 6 hours, or overnight to dissociate the homodimers into the respective 
monomeric units. The mixtures were subsequently dialyzed against 0.5 M (NH4)2SO4 in 
20 mM Tris-HCl, pH 7.9, containing 5 mM MgCl2 and purified via Phenyl Sepharose 
column as described for the preparation of the heterodimeric species. Removal of the 
chaotropic agents resulted in some precipitation of both proteins. No heterodimeric 
species was detected in the fractions eluted from the Phenyl Sepharose column. This may 
suggest a very specific binding between the two proteins, that cannot be mediated by 
simple dissociation and mixing of the monomeric units.  
 
4.2.2.6. Purification of E. coli GlucD mutants 
 The following GlucD mutants were generated and expressed out of a GlucD 
knock-out strain of E. coli K-12 in pET-16b vector using the pTara system as described 
in earlier chapters: single mutants S29G, P34A and Q102W; double mutant S29G P34A; 
and triple mutant S29G P34A Q102W. The mutants were expressed and purified as 
described for E. coli GlucD. The His-tags were removed with Factor Xa as described 
earlier for the proteins that were sent to Prof. Steven Almo’s lab for crystallographic 
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studies. All mutant proteins were stored in a 20 mM Tris-HCl, pH 7.9, containing 100 
mM NaCl and 5 mM MgCl2. 
 
4.2.3. 5-Keto-4-deoxy-D-glucarate aldolase-coupled assay 
 The kinetic constants for GlucD, GlucDRP and the GlucD mutant enzymes were 
determined with a spectrophotometric coupled-enzyme assay. The dehydration reaction 
was coupled to the 5-KDG aldolase which cleaves 5-KDG to tartronate semialdehyde and 
pyruvate. In the coupled system, pyruvate is then converted by the lactate dehydrogenase 
(LDH, Sigma) into lactate and consumption of NADH as a function of time is observed at 
340 nm. Typically, the assay was carried out in 50 mM Hepes, pH 8.0, in the presence of 
10 mM MgCl2, 0.16 mM NADH, 10 U LDH and 75 µM 5-KDG aldolase (Figure 4.7).  
 
 
Figure 4.7. Dehydration of D-glucarate is coupled to the 5-keto-4-deoxy-D-glucarate 
aldolase (5KDGA) and lactate dehydrogenase (LDH) in the coupled-enzyme assay. 
 
The linear range for the enzyme to be assayed at saturating substrate concentrations was 
determined before each experiment to ensure that NADH consumption was not rate 
determining. GlucD and the viable GlucD mutants (S29G, P34A and S29G P34A) used 
in the experiment were typically assayed in the range of 10-100 nM. GlucDRP and the 
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more impaired mutants (Q102W and S29G P34A Q102W) were typically assayed in the 
range of 0.5-1 µM. 
 
4.3. Preliminary hypotheses 
4.3.1. Analysis of multiple sequence alignment 
The only enzyme in the E. coli pathway whose function is still unknown is 
GlucDRP. Albeit very close in sequence to GlucD (~62%), the enzyme is impaired in the 
ability to dehydrate both D-glucarate and L-idarate. Although multiple attempts have 
been made, no crystal structure has been solved for GlucDRP. However, pair-wise 
multiple sequence alignment of GlucDs and GlucDRPs from multiple organisms reveals 
that the two enzymes differ mainly in the identities of the residues in the capping domain 
loops. Several of the residues that play a role in substrate recognition and loop closure in 
GlucD are different in GlucDRP and possibly contribute to the impairment of function. 
Several of these residues serve as hydrogen-bonding interaction partners that result in 
loop closure and substrate recognition in GlucD (Figure 4.8). It has also been suggested 
that perhaps GlucDRP serves an alternate non-catalytic function.  
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Figure 4.8. Partial multiple sequence alignment of the capping domain loops of 
GlucDs and GlucDRPs from select organisms. ote the highlighted residues, Ser 29, 
Gln 102 and Thr 103 of GlucDs. The interaction between these residues brings the 
20s and 100s loops together, resulting in closed loop configuration. 
 
4.4. Identification of GlucDRP as GlucD’s interaction partner 
 After it was realized that amidohydrolase superfamily members can form 
heteromultimeric complexes [54], it was hypothesized that a similar state may be possible 
in the enolase superfamily as well (e.g. in the case of GlucD and GlucDRP). However, 
the pI values of the two proteins are virtually identical, which makes it impossible to 
separate the two proteins via anion exchange chromatography. The two proteins also 
differ by only 291 Da in size, making the two proteins inseparable by gel filtration 
chromatography. However, it was realized by an experimental chance that the two 
proteins differ in surface hydrophobicity, making the two separable on a Phenyl 
Sepharose column. Based on an elution profile of a mixture of the two proteins, it was 
determined that GlucDRP is more hydrophobic than GlucD, and thus elutes in later 
fractions (Figure 4.9). The heterodimeric species was reproducibly determined to elute 
between the two homodimeric species.  
S. typhimurium M L L N I G G A H N A Y F T R N D T F G K G A WT F E L R V
S. flexineri M L L N I G G A H N A Y F T R N D T F G K G A WT F E L R V
E. coli GlucDRP M L L N I G G A H N A Y F T R N D T F G K G A WT F E L R V
E. carotovora M L L N I G G A H G A Y F T R N D S F G K G A WT F E L R V
S. typhimurium M L M N L S G A H A P F F T R N D A G G R G L Q T F D L R T
S. flexineri M L M N L S G A H A P F F T R N D A S G R G L Q T F D L R T
E. coli GlucD M L M N L S G A H A P F F T R N D A G G R G L Q T F D L R T
E. carotovora M L L N L S G A H A P Y F T R N D S S G R G L Q T F D L R I
S29 P34 Q102
T103
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Figure 4.9. An example of the expected elution profile of GlucD, GlucD/DRP and 
GlucDRP from the Phenyl Sepharose column (blue); decreasing gradient (0.5-0 M) 
of (H4)2SO4 is depicted with a red line. 
 
4.4.1. Screening of acid sugar libraries for dehydration activity  
 The acid sugar libraries were screened for additional dehydration activities with 
the GlucD/DRP heterodimer as described in the previous chapter. However, dehydration 
of only D-glucarate and L-idarate was observed. 
 
4.4.2. GlucD/DRP heterodimer kinetics with D-Glucarate and L-idarate 
 After the discovery of the heterodimeric complex of GlucD and GlucDRP, one of 
the hypotheses was that GlucDRP is allosterically activated when bound to GlucD. To 
investigate this hypothesis, the heterodimeric complex was characterized kinetically. 
However, no activation was observed. The kcat of the heterodimer is approximately 
halved (kcat of 11.7 s
-1) when compared to the wild-type GlucD enzyme (kcat of 20 s
-1), 
suggesting no activation of GlucD upon GlucDRP binding; the same is true with the L-
idarate substrate. For the assay, enzyme concentration of 10 nM was used (assuming 5 
 
A
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or
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e 
Elution time 
GlucD     GlucD/DRP    GlucDRP 
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nM of GlucD and 5 nM of GlucDRP). The rest of the kinetic constants can be found in 
Table 4.1. 
Enzyme Substrate KM (M) kcat (s
-1) kcat/KM (M
-1s-1) 
GlucD/DRP D-glucarate 45 x 10-6 11.7 2.6 x 105 
 L-idarate 130 x 10-6 13 1 x 105 
WT GlucD* D-glucarate 60 x 10-6 20 3.3 x 105 
 L-idarate 16 x 10-5 20 1.2 x 105 
GlucDRP* D-glucarate 32 x 10-5 0.06 1.7 x 102 
 L-idarate 17 x 10-5 0.01 7.8 x 101 
 * Hubbard et al., 1998 [51]. 
Table 4.1. Dehydration kinetics for the WT GlucD and GlucDRP as reported by 
Hubbard et al., and for the newly discovered GlucD/DRP heterodimeric complex. 
 
4.4.3. Discussion 
 E. coli K-12 substrain MG1655 was grown on minimal media supplemented with 
D-glucarate as the sole carbon source. GlucD activity was isolated and purified in 
multiple steps. GlucD activity eluted in two distinct fractions when separated based on 
hydrophobicity on a Phenyl Sepharose column. The later fractions contained the more 
hydrophobic GlucD/DRP heterodimer. These experiments provided the first example 
where two different enolase superfamily members form a heteromultimeric complex. 
Unfortunately, the meaning of this new biochemical evidence is unclear because no 
allosteric activation was observed for the heterodimer. 
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4.5. Conversion of GlucD into GlucDRP 
 All attempts to crystallize GlucDRPs from multiple organisms have thus far 
failed. The catalytic impairment of GlucDRP may be due to the differences in the key 
residues in the 20s and 100s loops sequences. To gain new insights into how substrate is 
bound in the GlucDRP active site and into the possible loop conformations of that 
enzyme, mutants of the E. coli GlucD were generated to mimic 20s and 100s loops of 
GlucDRP. Mutations were designed to yield a “minimal crystallizable GlucDRP.” The 
loop mutations provide new insights into the residues that are critical not only for 
substrate recognition but for loop closure and catalysis. Three residues were chosen for 
mutagenesis study: Ser 29, which in GlucD hydrogen bonds to Thr 103 and Gln 103, 
likely contributing to loop closure; Pro 34, which was expected to bear structural 
importance in shaping the 20s loop; and Gln 102 which is an important hydrogen bond 
donor to Ser29. All three residues are mutated in the GlucDRP (Figure 4.8). 
 
4.5.1. GlucD mutant enzyme kinetics 
 Altogether, five mutants were generated: S29G, P34A, Q102W, S29G P34A and 
S29G P34A Q102W. All mutant enzymes were expressed from a GlucD knock-out strain 
of E. coli K-12 in the pET-16b vector with the pTara system. The enzymes were 
characterized with the spectrophotometric coupled-enzyme assay as described earlier. 
The His-tags of the mutant enzymes were not removed because the kinetics for the WT 
GlucD and the 10-His-tagged GlucD were identical. Of the five mutants, the least active 
turned out to be the triple mutant, bearing most resemblance to the capping domain loops 
of GlucDRP. The triple mutant was determined to have a kcat of 0.01 s
-1, a KM of 300 µM 
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and a kcat/KM of 25 M
-1s-1. The previously reported value of kcat/KM for GlucDRP was 170 
M-1s-1 [51]. However, upon purifying GlucDRP from the GlucD knock-out strain of E. 
coli, it was determined that the correct value of kcat/KM was actually 37 M
-1s-1 due to an 
increase in the KM value (Figure 4.10). It is interesting to note that the second order rate 
constants are almost the same for both GlucDRP and the triple mutant, which was 
designed to mimic the loops of GlucDRP. The kinetic constants for all other mutants can 
be found in Table 4.2. 
 
Mutant KM (M) kcat (s
-1) kcat/KM (M
-1s-1) 
WT GlucD 57 x 10-6 19.4 3.4 x 105 
WT GlucDRP 14 x 10-4 0.05 37 
S29G 21 x 10-5 5.7 2.7 x 104 
P34A 58 x 10-6 18.3 3.1 x 105 
S29G P34A 47 x 10-5 6.3 1.3 x 104 
Q102W 91 x 10-5 0.04 48 
S29G P34A Q102W 33 x 10-5 0.01 25 
 
Table 4.2. Complete list of kinetics as determined for the WT GlucD, WT GlucDRP 
and the GlucD mutants, designed to mimic the GlucDRP capping domain loops. 
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Figure 4.10. The Michaelis-Menten plot for D-glucarate dehydration with GlucDRP, 
expressed from the GlucD knock-out cell line of E. coli. ote the increased KM value 
of 1.4 mM when compared to that of GlucDRPs 320 µM which was expressed from 
E. coli BL21 (DE3). Enzyme concentration of 1 µM was used for the assay. 
 
4.5.2. Importance of loops in substrate recognition 
 In the first chapter, examples were discussed of how substrate recognition is 
established by the residues in the capping domain loops. For example, the complex 
hydrogen bonding networks are required for the recognition of 2-phosphoglycerate in the 
enolase structure, and the Arg24 is required for the recognition of L-Ala-D/L-Glu 
substrate in AEE. In the previous chapter, FucD was discussed, where the series of 
hydrophobic residues from the loops confer the substrate specificity for the 6-methyl 
group of L-fuconate. Very similar substrate recognition characteristics can be seen in the 
case of GlucD. His 32 and Asn 27 are involved in the C1 carboxylate group recognition 
and are conserved between GlucD and GlucDRP. Asn 27 is also in the hydrogen-bonding 
distance of Thr 103 and likely contributes to the interaction between the 20s and 100s 
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loops. Thr 103 interacts with the C3 hydroxyl group of the substrate molecule and the Ser 
29 residue of the 20s loop. Ser 29 also interacts with Gln 102, thus completing the 
network of interactions required for both loop closure and substrate recognition (Figure 
4.11). It is easy to see how the substitution of Gln 102 and Ser 29 with a Trp and Gly 
residues, respectively, in  the GlucDRP can result in the lack of a hydrogen-bonding 
interaction network which impairs both loop closure and substrate binding. 
 
 
Figure 4.11. Stereo view of the GlucD capping domain loops from the top of the 
barrel. ote the hydrogen-bonding interaction network created by Asn 27, Ser 29, 
His 32, Gln 102 and Thr 103. The bound ligand is 4-deoxy-D-glucarate (PDB: 
1EC9). 
  
4.5.3. Discussion 
 The pathway for D-glucarate degradation in E. coli was first described by 
Blumenthal and Fish [55] in the 1960s. The crystal structures and the mechanism of 
GlucD were elucidated by our lab a decade ago. However, attempts to assign the function 
Pro34 Pro34 
His32 His32 
Asn27 Asn27 
Thr103 Thr103 
Gln102 Gln102 
Ser29 Ser29 
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of GlucDRP have failed. This may be due to a limited size of our compound library but 
also to an incomplete knowledge of the types of functions enolase superfamily members 
may carry out in the cell. GlucD and GlucDRP are the first example of proteins in the 
enolase superfamily that form a heterodimeric complex in vivo. Although the function of 
this complex is unknown to us, it is an important addition to our understanding of the 
enolase superfamily. The mutagenesis study of the loops identified Gln 102 as an 
important residue to complete the hydrogen-bonding interaction network between the 20s 
and 100s loops. Although GlucDRPs have proven to be difficult subjects for X-ray 
crystallography, structural studies of the mutant GlucDs are under way in Prof. Steven 
Almo’s lab at AECOM. The GlucD mutant structures will likely answer some important 
questions about the structural basis for the catalytic impairment of GlucDRPs.  
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